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Abstract 
Introduction 
Mindfulness-Based Therapies (MBT) are a current technology within the cognitive-
behavioural tradition, which can be grouped according to whether mindfulness is a 
major or a minor component. A mindful approach to psychological difficulties attempts 
to change the relationship with unwanted inner experience. The model suggests this 
may help reduce affective symptomatology. There has been a considerable growth of 
interest in these therapies with an accompanying increase in the evidence base. A 
number of reviews have been conducted however they have not comprehensively 
appraised these therapies. The primary aim of my study was to contribute to ongoing 
research determining the effectiveness of MBT for the treatment of affective 
symptomatology. Depending on these results, a secondary aim of the study was to 
make recommendations for the use of MBT in clinical practice. 
 
Methods 
I conducted a meta-analysis which looked separately at therapies considered to have 
mindfulness as a major component; therapies considered to have mindfulness as a 
minor component; and a comparison of these two groups. Of the 598 unique citations 
identified in the literature, 113 were assessed for eligibility and 40 included in the pool 
of studies for the meta-analysis. 
 
Results 
For the major component therapies, there was a significant mean reduction score in 
depressive symptomatology as measured by the BDI of 8.73 points (k = 11; 
95% CI = 6.61, 10.86). Evidence of effectiveness was also found for the minor 
component therapies (k = 8) in reducing anxiety symptomatology with a significant 
standardised mean difference of 1.24 (95% CI = 0.81, 2.10). 
 
Discussion 
I found evidence for the effectiveness of mindfulness-based therapies in reducing 
levels of depression or anxiety mainly in patients diagnosed with depressive or 
anxiety disorders. The robustness of these findings is discussed alongside the 
implications for research and practice within the context of the current literature. 
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“Feelings come and go like clouds in a windy sky. 
Conscious breathing is my anchor.” 
 
Thich Nhat Hanh 
 
 
1. Introduction 
1.1 Chapter outline 
In this chapter I introduce the concept of mindfulness and detail how it is applied to 
clinical psychology practice in the form of the mindfulness-based therapies. I will 
detail some of the basic concepts and techniques of these therapies, show the linked 
factors, and illustrate how they work. The historical context of these therapies is then 
considered before introducing the current evidence base. The chapter ends by 
detailing the rationale, aims and objectives of my research. 
 
1.2 What is mindfulness? 
Mindfulness is a form of focused awareness that is intentional and directed to the 
present moment, with a specific motivation of accepting unconditionally what is 
revealed or apparent in that moment. A number of definitions of mindfulness exist 
(Mace, 2008), although they generally share these common characteristics. One of 
the main challenges that researchers face in the field was agreement as to what 
mindfulness is and on operationalised definitions enabling its quantification. 
 
Jon Kabat-Zinn, a leading proponent of mindfulness in the West, describes it as 
“paying attention in a particular way, on purpose, in the present moment, and non-
judgementally” (Kabat-Zinn, Lipworth, & Burney, 1985). Whether an emotional 
dimension is essential to the practice of mindfulness is the subject of debate. Some 
see mindfulness as having a neutral stance towards emotions – as emotionality can 
be seen as a form of judgement – whereas others see ‘loving kindness’ as an 
essential motivation and intrinsic to practice (Hanh, 1991). 
 
I think the plethora of definitions reflects the inherent nature of mindfulness: it is 
essentially a subjective, personal experience as its core elements are awareness and 
focus. 
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1.3 Mindfulness-based therapies 
Mindfulness-Based Therapies (MBT1) use mindfulness to cultivate an increased 
awareness in the moment with the intention of alleviating the distressing effects  of 
physical and psychological health problems (Germer, 2005). Mindfulness has been at 
the centre of meditative traditions dating back thousands of years (See 1.7.1) 
however its formalisation as a ‘Western’ therapy is a relatively recent endeavour 
(Baer & Krietemeyer, 2006). 
 
Mindfulness techniques have been very broadly applied within clinical psychology 
and this broad application has created a number of distinct therapies with 
considerable commonality. In some cases these applications are developed from 
existing models; for other therapies there was a parallel development with a 
purportedly different theoretical base. 
 
1.3.1 ‘Mindfulness-based’ practices 
The first established mindfulness-based therapy was Mindfulness-Based Stress 
Reduction (MBSR). A number of other therapies with the prefix ‘mindfulness-based’ 
have been derived from MBSR and so will be considered together. The most 
prominent therapy developed from MBSR was Mindfulness-Based Cognitive Therapy 
(MBCT). 
 
In MBSR and MBCT the mindfulness techniques form the substantive component of 
the therapy and both were designed for administration in a group format over an 
eight-week course (see 1.4 for more detail on specific techniques). MBSR was 
initially developed for stress reduction and the management of chronic pain. MBCT 
was specifically developed to prevent relapse in recurrent depression and its 
originators acknowledge that there was as much as an 80% overlap between MBSR 
and MBCT (Segal, Williams, & Teasdale, 2002). 
 
Other therapies developed from MBSR include: Mindfulness-Based Eating 
Awareness Training (MB-EAT) for eating disorders (Kristeller & Hallett, 1999); 
                                               
1
 See Appendix 6.1 for a list of all abbreviations and acronyms used throughout this thesis 
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Mindfulness-Based Pain Management (MBPM) (Gardner-Nix, Backman, Barbati, & 
Grummitt, 2008); Mindfulness-Based Relapse Prevention (MBRP) for recovery from 
substance abuse and addiction (Witkiewitz, Marlatt, & Walker, 2005); and 
Mindfulness-Based Relationship Enhancement (MBRE; Carson, Carson, Gil, & 
Baucom, 2004). Similarly these therapies have considerable overlap with MBSR 
however they are specifically tailored for the target condition. There are also 
examples of therapies which draw heavily from mindfulness but do not have the 
prefix: for example Mindful Awareness Practices (MAP; Zylowska, et al., 2008). 
 
The distinguishing feature of these mindfulness-based practices was that the 
mainstay of the therapy was the mindfulness technique and its practise. What 
differentiated them was their tailoring to specific conditions. These therapies could be 
considered to have mindfulness as a ‘major’ component of the intervention. There are 
also several key themes behind this group of therapies which include acceptance; 
distancing from unwanted internal experience; and adopting a compassionate stance 
to one’s psychological experience. These themes show some overlap with 
Acceptance and Commitment Therapy. 
 
1.3.2 Acceptance and Commitment Therapy 
Acceptance and Commitment Therapy (ACT – pronounced as the word) was 
developed by Steven Hayes and originally known as ‘comprehensive distancing’ 
(Steven C. Hayes, 1987). Hayes reported that this was a reference to Aaron Beck’s 
use of the term ‘distancing’ to refer to an objective awareness of one’s thoughts. This 
can be compared to metacognition: an awareness of one’s own cognitive processes 
and the use of this awareness in their regulation (A. Brown, 1987). This reference to 
Beck’s work was testament to the lineage of Hayes’ model: he conceptualises ACT 
firmly within the CBT camp, built on an empirically tested theory of language and 
cognition (Relational Frame Theory: Steven C. Hayes, Barnes-Holmes, & Roche, 
2001). 
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ACT is defined as: 
“A therapy approach that uses acceptance and mindfulness processes, and 
commitment and behaviour change processes, to produce greater 
psychological flexibility.” 
(p13: Steven C Hayes & Strosahl, 2004) 
 
Psychological flexibility is established in ACT through a focus on the six core 
processes of the model (From Harris, 2006): 
• Cognitive defusion: learning to perceive thoughts, images, emotions, and 
memories as what they are, not what they appear to be; 
• Acceptance: allowing them to come and go without struggling with them; 
• Contact with the present moment: awareness to the here and now 
experience with openness, interest, and receptiveness; 
• Self as context: accessing a transcendent sense of self, a continuity of 
consciousness which is changing; 
• Values: discovering what is most important to one's true self; 
• Committed action: setting goals according to values and carrying them out 
responsibly. 
 
Developments from the ACT model include Acceptance-Based Behaviour Therapy 
(ABBT; Roemer, Salters-Pedneault, & Orsillo, 2006), which lies more fully within the 
behavioural camp however it makes use of acceptance and mindfulness techniques. 
ACT and ABBT could be considered to have mindfulness as a relatively ‘minor’ 
component of the intervention. 
 
1.3.3 Metacognitive Therapy 
Metacognitive Therapy (MCT) was developed independently by Adrian Wells, and 
also has its foundations in theory: the Self-Regulatory Executive Function (S-REF) 
model of understanding emotional disorder through attention processing (Adrian 
Wells, 2005). MCT proposes that a thinking style termed Cognitive Attentional 
Syndrome (CAS) lies at the foundation of all psychological disorders and was what 
prolonged and intensified negative emotion (Adrian Wells, 2008). CAS involves worry 
and rumination; threat monitoring; and maladaptive coping behaviours. It involves 
excessive focus on the content of our thoughts and on strategies to eliminate those 
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thoughts. MCT aims to shift our focus from the content of thoughts to the experience 
of the thoughts and how they are regulated. Therapy focuses on our metacognition – 
our thinking about our thoughts – rather than on the content of the original thoughts. 
 
While this model holds a different explanation for why mindfulness may be effective, I 
think there is considerable overlap in clinical technique. Wells lists ten ‘detached 
mindfulness’ techniques (Adrian Wells, 2005) and I think they bare a striking similarity 
to techniques used in for example MBCT and ACT. 
 
MCT could be considered to have mindfulness as a relatively ‘minor’ component of 
the intervention. 
 
1.3.4 Dialectical Behaviour Therapy 
Dialectical Behaviour Therapy (DBT) is one of the most established and 
well-researched therapies that has a mindfulness component. DBT was developed by 
Marsha Linehan for a specific application: the treatment of Borderline Personality 
Disorder (BPD; Linehan, 1993). It is worth mentioning as it does employ mindfulness 
however it has not really been applied to treating the more common psychological 
difficulties outside of BPD. 
 
DBT comprises four components. Mindfulness is one of these components, however 
it is recognised that mindfulness skills also feature in the other three components 
(emotional regulation, interpersonal effectiveness and distress tolerance). For 
example, ‘observing the breath’ is situated within the distress tolerance module. 
 
A recent interesting study reported a component analysis of the skills used within 
DBT (Dewe & Krawitz, 2007). Of the 27 skills within the DBT manual, four from the 
mindfulness module appeared within the top 14 ranks. Another interesting study 
suggested mindfulness skills were some of the most frequently practised daily skills 
which had been taught as part of a DBT programme (Lindenboim, Comtois, & 
Linehan, 2007). DBT could be considered to have mindfulness as a relatively ‘minor’ 
component of the intervention. 
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1.4 The active components of the therapies 
To illustrate the practice of mindfulness and give a sense of how it may help provide 
therapeutic benefit, Table 1 details two common techniques within MBCT and their 
component parts. I have used MBCT to illustrate this as mindfulness is a major 
component of this therapy and MBCT has very much evolved within the cognitive 
paradigm. However the components are more generally applied across all of these 
therapies. 
 
Table 1. The active components of two mindfulness techniques 
 How this component is achieved in example techniques: 
Component The body scan Mindfulness of breath 
Attentional 
concentration 
Focusing attention on a specific 
area of the body 
Focusing attention on the 
breath 
Attentional flexibility Shifting this attention around the 
body  
Following the in-breath and 
out-breath 
Acceptance When tension or difficulty is found, 
breathing in and focusing and 
staying with the difficulty. 
Experiencing pleasant and 
unwanted events. 
Noticing and not trying to 
change the breath. Letting go 
of tension, no matter how 
small an amount 
Present moment 
experience 
Experiencing sensations in the 
body as they arise 
“Riding the waves of the 
breath sensations”; staying 
with the breath for the full 
duration of the in- and out-
breath 
Change Awareness of sensations ebbing 
and flowing  
Paying attention to the 
changing patterns of 
sensations 
Gaining perspective on 
mental processes, 
thought defusion’ 
Reconnecting with physiological 
experience 
Noticing the wandering mind. 
This increases awareness of 
the nature of the mind. 
Paradoxically by paying 
attention to the breath, in the 
moment we catch ourselves 
having drifted we gain 
insights into the working of 
the mind.  
Kindness (self-
compassion to self and 
body) 
When mind wanders, clients 
encouraged to gently bring 
attention back to breath 
Gently, kindly escorting 
attention back to the breath. 
Attitude to meditation. 
 
Mindfulness is a not a form of relaxation, although deep relaxation can and often is a 
by-product of it. There is considerable substance to the techniques themselves, with 
a number of ‘active’ components. Some of these components are inherently 
metacognitive. For example, being aware of ongoing and changing sensations 
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involves becoming aware of the flow of experience and the realisation that when we 
look at things in detail they are not as solid and permanent as we thought. 
 
These techniques cultivate a more flexible and skilful approach to unwanted affect or 
other inner experience. A mindful approach can then lessen the impact these 
experiences have by, for example, providing more perspective so they are less 
compelling; reducing attachment and being able to let go and move on from 
unwanted thoughts; and seeing affective states as less permanent and solid. 
Furthermore, by for example training concentration it may provide further behavioural 
benefits. 
 
1.5 How the therapies are linked 
There are a number of common elements amongst these therapies. These include 
acceptance as there is a strong emphasis on this within ACT, MBCT and MBSR; 
MCT talks of the problem of avoidance; and DBT agrees with the importance of 
developing an accepting stance to one’s inner experiences. The principal of defusion 
or distancing to achieve a meta-cognitive perspective on inner experience also 
seems to be a common principle. However it is achieved through different 
techniques: MBCT uses meditation, ACT uses metaphors, and MCT uses detached 
mindfulness. 
 
Increased contact with the present moment is another shared element which again is 
achieved through different techniques. MBCT and MBSR teach meditation for this 
purpose; MCT uses attention training; and ACT and DBT use mindfulness practices. 
Finally the ability to shift attentional focus is a common element. MCT uses attention 
training. MBCT and MBSR use, for example, the body scan (letting go and moving 
onto the next area of the body) and meditation; for example letting go of breath and 
shifting attention to different sounds. ACT uses metaphors, paradox, and personal 
experience. 
 
The purpose of Figure 1 is to help conceptualise the therapies included in this thesis; 
specifically their origins and the links between them. I recognise that there are many 
different ways to conceptualise the therapies and this is used mainly for illustrative 
purposes rather than as a definitive guide. There will inevitably be some blurring and 
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merging between the categories. Furthermore, the influences on the originators of the 
therapies are not always acknowledged or clear. For example, Adrian Wells would 
argue against meditation having had an influence on the development of MCT; 
despite the similarity between his detached mindfulness techniques and the 
acknowledged mindfulness techniques. 
 
The dates indicated by the time line are approximate and based on the first 
publications of studies or articles detailing the therapy. To have a useful time scale on 
the diagram, meditation was left undated as its origins are considerably earlier than 
these therapies (see Section 1.7.1). 
 
1.6 How the therapies differ to traditional CBT 
In making sense of a mindfulness-based approach to psychological difficulties and 
how they may be effective in their treatment, it was helpful to consider the basic 
mindfulness model within the context of the wider cognitive-behavioural approach. 
CBT is an umbrella term for a large number of therapeutic approaches that all have a 
theoretical basis in the behaviourist and cognitivist traditions. Furthermore, the 
mindfulness-based therapies discussed here could be considered to be the latest 
technologies within CBT. For the purpose of this comparison therefore I will consider 
the more ‘traditional’ CBT approach which stems from Aaron Beck’s 
conceptualisation of the model (Aaron T. Beck, 1976). 
 
Using the example of depression, CBT and MBT have a number of similarities which 
are summarised here. Both recognise and differentiate between thoughts, behaviours 
and emotions; and believe working with thoughts and behaviours was possible and if 
done so, can help us cope with our difficult emotions. Both also aim to engender an 
increased awareness of these components and the effect they can have on the other 
components. Once this awareness was achieved they part company. In traditional 
Beckian CBT there is a significant emphasis on helping clients to control internal 
events for example by learning to challenge thoughts; whereas MBT aims to help 
individuals accept their internal events and let them be, recognising them as just 
thoughts or feelings or part of inner experience. 
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Figure 1. A conceptualisation of the origins and influences on mindfulness therapies 
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A distinction is made between emotions that are appropriate and directly linked to an 
event, which are primary (or ‘clean’) emotions; and emotions that are a product of our 
response – through previous experience and learning, for example - to the primary 
emotion, which are known as secondary (‘dirty’) emotions (Steven C. Hayes, Luoma, 
Bond, Masuda, & Lillis, 2006). An event occurs, we may feel sad (primary emotion), 
however our struggle to not feel and accept this sadness – for whatever reason - 
causes us considerable additional suffering (secondary emotion). MBT aims to 
change the relationship with our internal events. It should also be recognised that 
while the technique differs they share the same goal: both approaches intend to 
reduce the negative impact we may experience from these events. To help 
conceptualise this idea the similarities and differences are shown in a considerably 
simplified way – and only for unwanted thoughts occurring through depression – in 
Figure 2. 
 
 
Figure 2. Simplified process diagram for CBT and MBT approaches to unwanted 
thoughts in depression 
 
In summary, MBT are thought to be effective through changing the relationship one 
has with unwanted thoughts. By not trying to change our inner experiences and by 
adopting a ‘non-doing’ or ‘non-striving’ mode through the practice of mindfulness, the 
purpose is to accept what is there rather than struggle to change it. By, for example, 
not ‘buying’ unwanted thoughts, it is reasoned that the thoughts will have a reduced 
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affective impact. Therefore by changing the relationship with inner experience it is 
likely that affective symptomatology will have a reduced effect. It is recognised that 
there is an inherent paradox in this approach: by letting go of one’s attempts to 
control one’s internal world - the control agenda – it actually gives more control of 
one’s life. Similarly by adopting an accepting stance towards inner experience the 
influence of unwanted inner experience will be less. 
 
1.7 The growth and development of mindfulness as a therapy 
In the West, the 1960s and 70s saw considerable interest in meditation practise and 
the benefits this could bring to enhance otherwise healthy lifestyles. The link between 
mindfulness and meditation was explored in more detail below (See 1.7.1). The 
application of this practise to mental health can be seen to gain momentum through 
reporting in the late 1970s and early 1980s (Boorstein, 1983; D. Brown, Forte, Rich, 
& Epstein, 1982; D. P. Brown & Engler, 1980; Deatherage, 1975; Kabat-Zinn, 1982; 
Kabat-Zinn, et al., 1985; Kutz, Borysenko, & Benson, 1985). However it has only 
been in the last decade that this interest has achieved a critical mass, as shown in 
Figure 3. This graphs the number of articles retrieved from the psycINFO® database 
containing the word ‘mindfulness’ - in either the title or the abstract – by year of 
publication. Admittedly these data are crude as they will contain unrelated articles as 
the word mindfulness was sometimes used in different contexts; and it also does not 
give a sense of the content of the articles. However it does give some sense of the 
growth of interest in mindfulness as a therapy as this is a database for psychological 
therapies. 
 
One of the most recognisable names associated with the development of a 
formalised mindfulness practice and technique for health problems – and so arguably 
the founding-father of MBT - is Jon Kabat-Zinn. In 1979 Kabat-Zinn founded the 
Stress Reduction Clinic at the University of Massachusetts Medical School. He also 
founded at the same University the Center for Mindfulness in Medicine, Health Care 
and Society. He began teaching Mindfulness-Based Stress Reduction (MBSR) at the 
inception of the Clinic in 1979 and the initial focus of MBSR was for the relief of 
chronic pain and stress-related disorders (Kabat-Zinn, 1982; Kabat-Zinn, et al., 
1985). 
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Kabat-Zinn has a longstanding interest in the application of mindfulness practice to a 
wide audience and has believed that benefit can be conferred to society as a whole 
by encouraging ‘healthy’ individuals to practise mindfulness regularly. For example 
his Center for Mindfulness teaches the course to business and health care 
professionals. 
 
As mindfulness gained momentum, it coincided with an important paradigm shift 
within psychology. In the 1950s the dominant paradigm within the field was 
behaviourism. This began to give way to cognitive models in the 1960s and 1970s. 
MBT is considered a development within the cognitive-behavioural tradition and a 
form of CBT. However it brings a different approach which Hayes described as the 
‘Third Wave’ of behavioural and cognitive therapy (Steven C. Hayes, 2004): following 
on from behaviourism, the first wave; and cognitivism, the second wave. 
 
The growth in mindfulness therefore coincided with the development of Cognitive-
Behavioural Therapy (CBT) and the two have become inextricably linked. For this 
reason my focus was on the use of mindfulness within the cognitive-behavioural 
tradition. There have however been intriguing suggestions that mindfulness may be 
an underlying factor for all forms of psychotherapy (Jeffrey R. Martin, 1997; Jeffery R. 
Martin, 2002). This theory suggests that all therapies work by helping us to become 
more aware of our mental processes. It has also been suggested that rather than an 
entirely new endeavour in Western traditions, mindfulness can be understood with 
reference to the larger body of literature on emotional regulation (Hofmann & 
Asmundson, 2008). Mindfulness is a form of emotional regulation (Blackledge & 
Hayes, 2001; A. M. Hayes & Feldman, 2004) and so it is possible that reference to 
the literature on emotional regulation may help develop it. However what 
distinguishes MBT is that within the modern field of clinical psychology it is the first 
therapeutic use of techniques that address inner experience in this particular way. 
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Figure 3. Crude number of ‘mindfulness’ publications, by year 1975-2008 
 
Thesis Page 26 
1.7.1 The link between meditation and mindfulness 
Meditation is a tradition with a written history spanning over 2500 years with possibly 
the earliest descriptions of meditation techniques in Buddhist texts (Gombrich, 1988). 
In the modern era meditation is indeed most widely linked with the Buddhist tradition 
although it plays some part in most Eastern as well as Western religions (Delmonte, 
1995; Flood, 2004; West, 1987). 
 
Within the Buddhist tradition, mindfulness is just one of a number of techniques used 
within meditation. Other techniques include concentration, tranquillity and insight 
practices. Indeed some researchers categorise different forms of meditation practice 
as Concentration Meditation (CM) and Mindful Meditation (MM) (Lazar, 2005). 
Examples of these include focusing on the breath (CM) or paying attention to the 
input from one or more of the senses (MM), such as listening and experiencing the 
sounds come into and drift out of our awareness. I question whether this is a useful 
distinction as a number of MBT will employ a focus on the breath, which technically 
would be more accurately described as a concentrative meditation technique (J. C. 
Smith, 2004). For example, within MBCT a number of techniques are presented, 
some of which could be considered concentration meditation (focusing on the 
breath), others mindfulness meditation (focusing on sounds). However with some, 
they can be practised mindfully or with a concentrative focus (for example, walking 
meditation). Participants of the group programme are positively encouraged to use 
the techniques they find useful or see as appropriate for them. 
 
1.8 Current evidence for mindfulness-based therapies 
There is a growing body of evidence that mindfulness is an effective therapeutic 
intervention (Baer & Krietemeyer, 2006); however systematic reviews and meta-
analyses are limited in number and scope. I will summarise systematic reviews of 
MBT for psychological therapies, which were published in the English language, in 
reverse chronological order. Firstly however, I will consider the purpose of 
evidence-based clinical practice. 
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1.8.1 Evidence-Based Clinical Practice 
Within the National Health Service (NHS) today, Evidence-Based Clinical 
Practice (EBCP) is currently the standard for clinical work and supported by the work 
of the National Institute for Health and Clinical Excellence (NICE). NICE guidelines 
considerably influence practice (Kendall, Pilling, Whittington, Pettinari, & Burbeck, 
2005) and indicate a clear need for methodologically rigorous, comprehensive 
reviews and meta-analyses of potentially useful therapies. 
 
The importance of summarising evidence to better understand the effectiveness of 
treatments, and thereby inform further research, is clear. EBCP is the application of 
the scientific method to healthcare. It was defined as, “an approach to decision 
making in which the clinician uses the best evidence available, in consultation with 
the patient, to decide upon the option which suits that patient best” (Muir Gray, 2008). 
It has become the framework in which health care is practised within many countries 
and a hierarchy of evidence is used to inform decisions. The Centre for Evidence 
Based Medicine publishes – with regular updates – what is effectively a hierarchy of 
evidence (CEBM, 2009). NICE also has a similar evidence-grading scheme 
(see Appendix 6.2). At the top of these hierarchies are systematic reviews of 
randomised controlled trials (which often include a meta-analysis). Then individual 
randomised controlled trials, followed by observational studies. At present, clinical 
trials form the backbone of this system. 
 
There is debate however over whether the clinical trial is an appropriate method for 
psychological therapies as it was designed for determining the effectiveness of 
pharmaceuticals. I think it is not possible to use placebo controls with trials of 
psychological therapies, however it is possible to offer other forms of control. 
Furthermore, it is important to consider other existing evidence to obtain a more 
comprehensive picture of treatment effectiveness. In psychological research, other 
designs are frequently used (Barker, Pistrang, & Elliot, 2002) and considered a useful 
addition to the evidence base. These include single-group designs; non-randomised 
two-group designs, which may use matched controls; and audits. While audits tend to 
have a lower external validity, they can inform the judgement as to whether a therapy 
is useful in everyday practice (high external validity). Reasons for this emphasis are 
often pragmatic. Funding is often a major factor for psychological studies (not 
supported by the wealth of pharma). However there may be strong ethical reasons for 
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not including a control group – such as there not being a position of equipoise in 
effectiveness between the intervention and the control. 
 
Explanatory trials are studies of the efficacy of a treatment and give an idea of 
whether an intervention can work under ‘ideal’ conditions. Pragmatic trials, on the 
other hand, are where effectiveness is tested; that is whether the intervention 
appears to work in routine clinical care (Howard, Moras, Brill, Martinovich, & Lutz, 
1996; Kazdin, 2003; Lambert & Ogles, 2003). Explanatory trials tend to optimise 
internal validity, with less ‘noise’ in the system, for example by having very strict 
inclusion criteria and not allowing the use of concomitant medication. They are often 
conducted in academic centres of excellence where treatment is of a very high 
standard, and so unfortunately not necessarily representative of practice in the wider 
world. If an intervention has equivalence with or outperforms another therapy, then it 
is deemed efficacious. 
 
The generalisability of such trials to wider clinical practice – the effectiveness of an 
intervention - is limited. This is where pragmatic trials come in, often drawing their 
sample from a wider population, representative of the variety of the patient population 
likely to be treated and aiming to inform choices between treatments. In pragmatic 
trials inclusion criteria for example tend to be more lax, concomitant medication is 
generally allowed and the control is more often than not a placebo. The intention it to 
reflect the real world of practice and so the decisions faced by clinicians. Pragmatic 
trials often compromise internal validity in order to maximise external validity, 
particularly in community-based studies or audits: the challenge is to maintain a 
balance between the two. Both types of trials are useful in building the evidence base 
for a treatment and in practice, the distinction between them is often not clear cut. 
Clinical trials lie somewhere on a continuum between explanatory and pragmatic 
trials and so often have characteristics of both. 
 
There is growing interest in using data from clinical practice to inform the 
decision-making process on best health care (Barkham & Parry, 2008). While there is 
debate about what constitutes good evidence, it is generally accepted that it is 
important to summarise evidence to better understand the effectiveness of 
treatments. This can then be used to guide practice and inform further research. 
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1.8.2 Published reviews 
1.8.2.1 Öst (2008) 
The most recent systematic review and meta-analysis which included a MBT was 
published by Öst (2008). This was a well structured, independent (Öst was not a 
practitioner of this form of therapy) review of what were described as the ‘third wave’ 
of behavioural therapies. Öst included therapies used as a primary treatment for 
psychiatric disorders and attempted to determine whether these therapies were 
empirically supported. 
 
An interesting issue raised in Öst’s article highlights some confusion in the use of the 
term ‘third wave of behaviour therapies’. This phrase was used by Hayes (2004) to 
refer to therapies that take a mindfulness-based approach to dealing with unwanted 
thoughts and emotions. In Öst’s article the criterion for third wave behaviour therapies 
seems to be those which emphasise the therapeutic relationship and acceptance. 
Therapies considered in Öst’s review that overlap with Hayes’ definition include 
Acceptance and Commitment Therapy (ACT) and Dialectical Behaviour Therapy 
(DBT). The remaining therapies considered do not – and include Cognitive 
Behavioural Analysis System of Psychotherapy (CBASP), Functional Analytic 
Psychotherapy (FAP) and Integrative Behavioural Couple Therapy (IBCT). While this 
debate does not render the article as unimportant to my review its definition does limit 
its relevance. Furthermore, Öst includes early studies by Zettle and Hayes (1986) 
and Zettle and Rains (1989) and categorises them as ACT. I think this was incorrect. 
These studies use technique which became incorporated in ACT and helped develop 
ACT as a therapy, however they do not include all of the theoretical and technical 
aspects we now understand as ACT. I think the eleven-year gap between the 
publication of Zettle and Rains (1989) and the next ACT study included in the review 
was evidence of this opinion. 
 
The review included a total of 13 RCTs investigating ACT and concluded that there 
was evidence of a moderate overall effect size of 0.66 when all types of control group 
were included. This was comparable to Hayes et al.’s (2004) finding of an effect size 
of 0.68 (see 1.8.2.4) – however this effect size was not reported in the original article. 
The review also included 13 RCTs investigating DBT, finding a moderate effect size 
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of 0.58. Sub-group analyses found the effect size was much larger for the studies 
with waiting list control groups, reported as 0.96 for ACT and 1.30 for DBT. 
 
Öst dealt with the problem of differences in study quality by matching these studies 
with contemporary CBT trials. He then assessed quality using a specifically 
developed scale based on one designed for studies of Post-Traumatic Stress 
Disorder (Tolin, 1999). Overall, Öst found the quality of the third-wave therapies to be 
somewhat less than for ‘matched’ trials of CBT. 
 
In conclusion I think this paper raises some interesting issues about MBT and gives a 
useful overview of the effectiveness of two forms of MBT. However this narrow focus 
on two minor-component therapies and the inclusion of all trials of all psychiatric 
disorders together does limit the review. 
 
1.8.2.2 Coelho, Canter & Ernst (2007) 
Coelho, Canter & Ernst (2007) recently reviewed the use of MBCT for preventing 
relapse in depression; the condition for which the therapy was developed. They 
reported on controlled clinical trials only, which limits the review, and found two 
randomised and one non-randomised study. A further paper was included providing 
an additional analysis on one of the randomised studies, which was reported slightly 
misleadingly as it was presented separately from the other study. A synthesis of 
these data was not attempted however they concluded that there was evidence of 
MBCT providing additional benefit to standard care for the treatment of recurrent 
depression (three or more episodes). They also concluded that it was important to 
investigate the specific effects of MBCT; that is the contribution of the therapy 
components rather than for example the therapeutic relationship. The reviewers 
argued that it was not yet possible to draw firm conclusions from the presented data 
because the control groups could not control for specific components of the active 
treatment but only for the attention and expectancy effects towards improvement. 
 
There were no language restrictions to the search, which covered a number of 
databases. To avoid publication bias the reviewers did not exclude dissertations or 
unpublished manuscripts. While this strategy ensured high sensitivity it was ultimately 
redundant: all of the included studies were published in English and in peer-reviewed 
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journals. By looking at depression only this review provides a narrow focus ensuring 
comparability of the studies. However this was a limitation at the same time: there 
was interest in the broader application of this technology and emerging evidence for 
its benefit in the treatment of anxiety (Evans, et al., 2008; Finucane & Mercer, 2006; 
K. Yook, et al., 2008), insomnia (Heidenreich, Tuin, Pflug, Michal, & Michalak, 2006) 
and bipolar disorder (Williams, Russell, & Russell, 2008). Some of these studies pre-
date the review and may have been useful to include. 
 
I think it was confusing to include reported outcomes that “indicate a change in 
mental health (including relapse data) or in symptoms, constructs, or precursors of a 
mental health problem” (my emphasis in italics). Including pre-cursors seemed 
unusual particularly for a therapy aimed at relapse prevention. It appeared to be a 
post-hoc criterion (where a way was found to include interesting studies in the 
review). The “precursors to a mental health problem” they reported was measured by 
the Autobiographical Memory Test (Williams & Broadbent, 1986), which was used as 
an outcome in the study that presented a new analysis of a previously published trial. 
An overgeneralised categorical memory may play a part in depressive thinking 
however it is not clear whether it is a causal factor and may be a confounder, linked 
to dependent and independent variables. Overgeneralised memory may be a feature 
of depressive thinking rather than a cause. 
 
Finally, in summarising the trials they did not report according to the internationally 
recognised QUOROM guidelines (Quality of Reporting of Meta-analyses; Moher, et 
al., 1999). These guidelines aim to increase the transparency of meta-analyses. Not 
all meta-analyses are the same and by detailing the method and rationale sufficiently 
it allows a better judgement of potential sources of bias introduced into the process. 
Decisions are made on, for example, which studies to exclude and it would have 
been useful to know exactly what these decisions were and what numbers were 
excluded. An example of this lack of reporting by Coelho, Canter & Ernst was failing 
to disclose the number of identified citations in the initial search. 
 
1.8.2.3 Toneatto & Nguyen (2007) 
This review (Toneatto & Nguyen, 2007) summarised the evidence for MBSR in the 
treatment of anxiety and mood disorders. They reported on controlled studies in the 
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literature and identified 15 which met their inclusion criteria. While the reviewers 
looked across clinical populations they focused on anxiety and depression outcomes. 
They did not attempt a meta-analysis with these data. 
 
Similarly to other reviews, but to a much greater degree, the reporting does not follow 
QUOROM guidelines. Information was not provided on the search strategy, the 
search dates, the number of citations found, how many studies met their eligibility 
criteria or which reviewers undertook which tasks. 
 
They raise an important point regarding adherence to the MBSR programme and 
provide an interesting summary of variations and adaptations to the original MBSR 
programme. However, they make no reference whatsoever to MBCT in the main text 
of the review (it appears only in the table of included studies). Although its developers 
admit it was derived from MBSR and shares about 80% of the course (Segal, et al., 
2002), MBCT has clearly developed into a therapy in its own right. They have 
included two studies which investigated MBCT (Ma & Teasdale, 2004; Teasdale, et 
al., 2000). Furthermore, they illustrate the importance of clear, QUOROM-level 
reporting: assuming their aim was to include MBCT, they have overlooked some 
important trials in this area, (for example: Williams, Teasdale, Segal, & Soulsby, 
2000). Although this study was not a unique population it was included in another 
review (Coelho, et al., 2007). 
 
They concluded tentatively that there was no evidence for a reliable effect on 
depression and anxiety, although intriguingly a previous meta-analysis (Grossman, 
Niemann, Schmidt, & Walach, 2004) did find a reliable effect size for MBSR. Toneatto 
and Nguyen’s review came to a different conclusion as they were more stringent on 
their inclusion criteria, with only controlled studies considered; and investigated a 
much narrower band of conditions. They did acknowledge that variation in 
methodological quality of the studies meant that a strong conclusion could not be 
drawn. I think consideration of the different clinical populations the studies recruited 
from would have been useful. 
 
I think their inclusion of published trials only was useful, however in their conclusion 
they misrepresent the previous reporting of a review also investigating MBSR 
(Grossman, et al., 2004). Grossman et al.’s review included unpublished trials 
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however their reference list indicated four of the 10 included controlled trials were 
published. Toneatto and Nguyen comment that only one in 10 were published 
studies. This was a minor point, which may be a genuine mistake. However it was 
used to stress a point about their study and alongside the inclusion of MBCT, it raises 
questions about the thoroughness of their approach and their knowledge of these 
therapies. 
 
1.8.2.4 Hayes, Masuda, Bissett, Luoma, & Guerrero (2004) 
This descriptive review (Steven C. Hayes, et al., 2004) was of third-wave of 
behavioural therapies, and includes ACT, DBT and Functional Analytic 
Psychotherapy (FAP). Similarly to the Öst review (Ost, 2008) discussed above, it has 
linked ACT to therapies that share an emphasis on the therapeutic relationship rather 
than the mindfulness component; hence the inclusion of FAP. This review was a 
useful summary of the existing research. However they did not conduct a systematic 
review and analysis of the literature and I think this leaves open the possibility of bias 
in the conclusions. The lead author is the originator of ACT and it appears that the 
authors have not taken a neutral stance in their investigation. In their defence they 
are clear about the purpose of the article. They appear to be responding to a specific 
criticism of these being empirically supported treatments (Corrigan, 2001) and as 
such, they have responded to this criticism by providing evidence of effectiveness. 
They have focused on the positive gain from these therapies and while this was 
useful, they have not attempted to provide a critical appraisal of the evidence. I would 
agree with their conclusion that these forms of therapy show a commitment to 
empiricism, but I would disagree that this review alone addresses the concern that 
claims of effectiveness and empirical support were excessive. 
 
The review of the evidence base for ACT included eight RCTs, two other forms of 
group studies and 14 case studies (mostly with n = 1). The review has been very 
inclusive of conditions, including studies of ‘mathematics anxiety’ and substance 
misuse (including smoking cessation); which are possibly unlikely to be the target of 
intervention for clinical psychologists within a mental health service. Similarly five 
RCTs of DBT for treating BPD were found, reporting benefit. Two studies of DBT for 
eating disorders were also found, again reporting benefit. 
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As stated no synthesis of these data was attempted however they conclude that there 
was evidence of effectiveness across a wide range of conditions. In this review all 
forms of study were considered and so a number of case reports were considered as 
representing a substantial contribution to the evidence base. They do however in the 
conclusion raise the issue of shortcomings in the evidence, including methodological 
quality, the depth of evidence within certain conditions and the clear need for more 
research. 
 
1.8.2.5 Grossman et al. (2004) 
Grossman et al.’s (2004) meta-analysis looked specifically at clinical trials of MBSR. 
It found 64 studies, however only 20 met the criteria specified by the reviewers. 
These exclusions were mostly made on the basis of quality of reporting (either of the 
intervention used or of the analysis). They found a similar (medium) effect size for 
both controlled and uncontrolled studies of approximately 0.5. The reviewers were 
very clear on the requirements of the studies in terms of the therapy provided, for 
example the review specifies course length, format. Furthermore, they required 
studies to operationalise a definition of mindfulness. This review’s search strategy 
included studies up to December 2002 and was therefore over six years old at the 
time of my study. At a time when publications are growing rapidly it was likely that 
there have been additional studies to consider. Furthermore they included non-
published studies. While this has some value, as these provided the majority of these 
data (six of the 10 controlled studies were unpublished), it indicated a sub-group 
analysis to determine whether this was linked to, for example, quality or outcome. 
 
The reviewers included unpublished studies, identified though contact with first 
authors of published studies. This ensured thoroughness, however it may have led to 
studies being included which were not peer-reviewed. The review only considered the 
short-term response to therapy (pre- to post-intervention). They reported not including 
long-term follow-up data because of the variation in these data (different time points, 
not consistently reported across studies). This narrowed the focus and left important 
questions relating to the maintenance of therapeutic benefits unaddressed; thereby 
limiting the usefulness of the review. 
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Although not compulsory, the review did not adhere to QUOROM guidelines (Moher, 
et al., 1999) on the reporting of systematic reviews of clinical trials. Specifically they 
did not provide data on the number of citations identified by their search strategies 
and the number of citations from the different sources. This was not a major flaw of 
the review however it makes the review lose some transparency which is the purpose 
of the QUOROM guidelines; it makes it difficult for example to replicate or test the 
methodology of the review. Furthermore the search terms were limited with the 
search comprising of a total of five keywords or phrases. 
 
My main concern with the analysis was their technique of aggregating across 
different outcome measures to calculate average effect sizes for the studies. This 
was useful in simplifying and making sense of a complex data set, however I think 
they have used far too crude a grouping and the subtleties of these data are lost. The 
review combined all outcomes for each of the studies into one of two groups: those 
measuring change in ‘physical’ health and those measuring ‘mental’ health. 
 
I think one of the problems with this was that the categorisation could be debated. 
Examples of this included ‘sleep’, which may be an important part of depressive 
symptomatology however I would not consider it a measure of ‘mental’ health, as the 
authors did. Some scales, for example the SF-36, have explicit components that 
measure physical functioning and mental health. Social functioning on the SF-36 may 
be effected by physical or mental health. Also ‘affective perception of physical pain’ 
seemed to present considerable ambiguity for me in deciding whether it was 
‘physical’ or ‘mental’ health (the authors considered it ‘mental’ health). 
 
It is common practice to group outcomes to clearly defined categories – for example 
all outcomes measuring ‘quality of life’ are analysed together (that is the effect sizes 
are combined). However it was unusual to group disparate scales as the authors 
have done and I think this does limit the usefulness of the findings. For example, 
when translating this into clinical practice, stating MBSR has a positive effect on 
mental health in general is not as useful as knowing whether or not it would have an 
effect on depressive symptomatology. 
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1.8.2.6 Baer (2003) 
This review (Baer, 2003) looks at MBT more generally; and included MBSR, MBCT, 
DBT, ACT and Relapse Prevention (RP). RP is a therapy that uses mindfulness 
techniques specifically for the prevention of relapse in substance abuse. Baer’s 
review provides a useful summary of the area and I think by drawing parallels 
between therapies that employ mindfulness and combining them in a review, 
provided a more comprehensive understanding of the technology. One interesting 
element of this review was the categorisation of the therapies into ‘interventions 
based on mindfulness training’ (MBSR, MBCT) and ‘interventions incorporating 
mindfulness training’ (DBT, ACT and RP). A therapeutic approach left out was 
Transcendental Meditation (TM) and other ‘concentration-based’ approaches. Baer 
argues that TM primarily employs concentration meditation techniques and so falls 
outside of the scope of the review. I think the distinction within the more recent MBT 
is unclear as they do incorporate concentrative techniques. However I do think they 
fall outside of the scope of such reviews for other reasons: while TM arguably played 
a considerable part in paving the way and informing MBT, it was no longer of 
considerable therapeutic interest. 
 
Those interventions that incorporated mindfulness training were required to 
specifically assess or control for the mindfulness component. As none were found 
that actually did this, these studies were not incorporated in the review. Of the MBSR 
and MBCT studies included, Baer reported many methodological flaws with the 
literature. For example, there was a paucity of controlled research; sample sizes were 
small; there were few descriptions of therapist training and evaluations of the integrity 
of the treatments; and a lack of focus on clinical significance. However the reviewed 
studies did show promising evidence in the treatment of several disorders. 
 
Insufficient information was provided on the methodology of the review, as was 
common with many other of the reviewers detailed here. The search dates, the 
number of citations found and the number or details of those not meeting the 
eligibility criteria were not provided. Baer summarises the studies by clinical 
population, which was a very useful categorisation. The analysis of these included 
studies was limited. 
 
Thesis Page 37 
Baer reported effect sizes for the studies separately. Baer then used basic meta-
analytic technique and averaged these effect sizes, weighted by the sample size. The 
post-treatment effect sizes ranged from 0.15 to 1.65 and the overall mean effect size 
was 0.74 (standard deviation (SD) = 0.39). When weighted by sample size the post-
treatment effect size was 0.59. Follow-up data were reported less often. The mean 
effect of the available follow-up effect sizes ranged from 0.08 to 1.35, with a weighted 
overall mean of 0.59 (SD = 0.41). 
 
I felt that the approach to follow-up data made the meaning difficult to interpret. 
Multiple follow-up points were averaged within studies before combining and across 
studies represented a follow-up window of 2-36 months. This was a very broad time 
period and I think should have been grouped to similar periods, so as to be intuitively 
more comparable. For example, the clinical significance of a two-month in contrast to 
a three-year follow-up is very different. A minor technical point relates to the reporting 
of standard deviations for the pooled effect sizes. I think a more useful (and 
conventional) statistic would have been the 95% confidence interval. 
 
Baer provided some very useful sub group analyses and concluded that the effect 
may be greater for Axis I disorders (American Psychiatric Association, 2000) as 
compared to chronic pain or medical problems. One final point Baer made was that 
the clinical significance of the estimated effect sizes was difficult to assess because 
of the poor reporting of data within individual studies (for example, where there was 
no mention of the pre-treatment score). For this and other reasons, increased 
methodological rigour in future studies was recommended. 
 
1.8.2.7 Other miscellaneous reviews 
A number of other systematic reviews of MBT have been published, however they fall 
outside of the scope of this review and so have not been summarised here. For 
example Smith et al.’s paper (2005) systematically reviews the use of MBT as a 
supportive therapy for cancer care; a physical health condition. Hayes et al. (Steven 
C. Hayes, et al., 2006) summarise the evidence base for ACT. However this was 
actually a very broad overview of the ACT literature and does not focus specifically 
on outcome studies. For example, it includes a number of surveys that administer 
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ACT specific outcome measures (Batten, Follette, & Aban, 2001; Begotka, Woods, & 
Wetterneck, 2004). 
 
Wells’ paper on MCT (Adrian Wells, 2008) provides a descriptive review of a number 
of studies claiming effectiveness for his therapy. The Melbourne Academic 
Mindfulness Interest Group published a useful overview of the area (Allen, Blashki, & 
Gullone, 2006) however the section on empirical evidence was very short, comprising 
of a very limited description of select papers. However they conducted a useful 
overview of potential adverse consequences of meditative practises (See 1.8.4). 
 
Two other interesting reviews investigated meditation techniques and included for 
example different forms of yoga. This broad scope limits their usefulness here. These 
were a Cochrane systematic review of meditation therapies for anxiety disorders 
(Krisanaprakornkit, Krisanaprakornkit, Piyavhatkul, & Laopaiboon, 2006) and a 
systematic review of meditation techniques for medical illness (Arias, Steinberg, 
Banga, & Trestman, 2006). 
 
1.8.3 Summary of existing reviews 
Published reviews of MBT suggest there is considerable evidence for their 
effectiveness. However these reviews have either been of only one or two specific 
forms of the therapy (Coelho, et al., 2007; Grossman, et al., 2004; Steven C. Hayes, 
et al., 2004; Ost, 2008); or were systematic reviews employing at the most some 
basic meta-analytic techniques rather than including a rigorous meta-analysis (Baer, 
2003; Toneatto & Nguyen, 2007). Furthermore, some of these reviews focus on 
specific conditions; not necessarily focused on psychological health. These factors 
limit their scope. 
 
I think these therapies share considerable common ground and form the leading 
edge of technology within the cognitive-behavioural tradition. There was a clear 
rationale for considering the therapies together to address the question of whether 
mindfulness is a useful treatment modality. 
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1.8.4 The safety of mindfulness-based therapies 
Shapiro (1992) authored an interesting early study of adverse mental and physical 
health events amongst long-term meditators. An adverse event was defined by the 
practitioner reporting the event and he found a very high prevalence. The criteria 
meant an adverse event could, for example, be regarded as an increased awareness 
of negativity within oneself; and it could be argued that this is one of the purposes of 
mindfulness. Shapiro does recognise this and comments that adverse events can be 
transformed over time. I think this limits the usefulness of the study. However an 
important point it made was highlighting the skills of the therapist required in 
containing and addressing difficulties arising from the practice. 
 
This point was further reinforced by Walsh and Roche (1979): a seminal paper which 
originated the thinking that meditation was contra-indicated by psychosis. This paper 
was actually a report of three cases where psychotic episodes occurred after 
engaging in intensive meditation. Firstly, as the authors state, a “combination of 
intensive meditation, fasting, sleep deprivation, a history of schizophrenia, and the 
discontinuation of maintenance doses of phenothiazines can be hazardous”. I 
couldn’t agree more; however case reports are uncontrolled and it was unclear which 
of these components – or which combination of these components - were 
responsible. Case reports are anecdotal and while they can make associations, 
definitive conclusions cannot be drawn. Furthermore, the intensive meditation may 
have been an attempt at self-medication during the early signs of a psychotic 
episode. What it does clearly show is the need for an appropriately trained 
practitioner to work therapeutically with a mental health population. 
 
A useful overview of MBT by the Melbourne Group (Allen, et al., 2006) drew attention 
to some important issues for practitioners. These included the opportunity cost of 
time invested in practice. For example, the MBCT course (Segal, et al., 2002) 
encourages significant home practice – 45 minutes a day – while undertaking the 
course and the expectation is that practise ultimately becomes integrated into daily 
activity. The Melbourne Group also considered exacerbation of symptomatology and 
recognised how an increased awareness of internal processes may pose difficult 
challenges for some individuals. However they concluded that this difficulty is often a 
stage that is passed through and again highlighted the importance of training from 
skilled practitioners. 
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There was an absence of serious concern in the literature about the safety of 
mindfulness practices and a paucity of adverse event reporting. This suggests an 
overview of safety was not currently indicated. 
 
1.9 Rationale, aims and objectives 
1.9.1 Rationale 
MBT are increasingly used within the field of mental health, particularly by clinical 
psychologists (Didonna, 2009; Germer, Siegel, & Fulton, 2005; Steven C. Hayes & 
Strosahl, 2005; Mace, 2008; Segal, et al., 2002). Proponents of MBT consider their 
application to be broad. For example, a recent guide on the practical application of 
Acceptance and Commitment Therapy (ACT) includes chapters on affective 
disorders; anxiety disorders; post-traumatic stress disorder; stress more generally; 
substance abuse and dependence; working with the seriously mentally ill; and 
working with chronic pain patients (Steven C. Hayes & Strosahl, 2005). Furthermore, 
MBT seems to be a useful intervention for individual as well as group work (Segal, et 
al., 2002) and across the lifespan (Didonna, 2009). 
 
The current and growing importance in the field of clinical psychology was further 
evidenced by the number of journals that have recently devoted or included a 
substantial element of an issue to a particular form of or all MBT. These include the 
Journal of Clinical Psychology (65(6): 2009); Behavioural and Cognitive 
Psychotherapy (36 (special issue 06): 2008); the Journal of Rational-Emotive & 
Cognitive-Behavior Therapy (23 (2) and 23 (4): 2005; and 24 (1): 2006); Behavior 
Therapy (35(4): 2004); and Clinical Psychology (10(2): 2003;  11(3): 2004; and 
15(4): 2008). 
 
In today’s NHS there is a clear need for professional practice to be empirically 
supported and organisations such as NICE facilitate this for the NHS. One method of 
determining whether therapies are effective is through meta-analysis. Reviews 
summarising specific forms of MBT have been conducted but are limited in scope 
(Baer, 2003; Coelho, et al., 2007; Grossman, et al., 2004; Steven C. Hayes, et al., 
2004; Ost, 2008; Toneatto & Nguyen, 2007). A comprehensive systematic review and 
meta-analysis of MBT would therefore provide a more rigorous overview of the 
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effectiveness of MBT. Additionally such a review may help indicate possible 
moderators of effect to inform future research. 
 
Psychological problems are common, with the point prevalence of any ‘neurotic 
disorder’ estimated at 17.3% for working-age adults in Great Britain (ONS, 2000). 
Current treatment options for anxiety and depression are effective and the benefit of 
psychological therapy was recognised (McIntosh, et al., 2004; NICE, 2007); however 
current treatment options are not effective for everyone. 
 
In developing guidelines for the treatment of commonly seen psychological difficulties 
the focus is on the reduction of symptomatology. Arguably, clients approach mental 
health services also see symptom reduction as an important indicator. It was 
hypothesised that MBT can reduce affective symptomatology through changing the 
relationship with this symptomatology. 
 
1.9.2 Aims 
The primary aim of my study was to contribute to ongoing research determining the 
effectiveness of MBT for the treatment of affective symptomatology. Depending on 
these results, a secondary aim of the study was to make recommendations for the 
use of MBT in clinical practice. 
1.9.3 Objectives 
The objectives of this research were where possible to: 
 
• To undertake a comprehensive search of the literature to identify relevant 
studies that have employed experimental and non-experimental designs of 
MBT in treating psychological health conditions; 
• To undertake a systematic review of this literature; 
• To evaluate the effectiveness of these therapies through the meta-analysis of 
relevant studies; 
• Where indicated, to undertake subgroup analyses of those relevant data to 
investigate possible moderators of effect; 
• To make recommendations on research; 
• To make recommendations on practice. 
Thesis Page 42 
1.10 Chapter summary 
In this chapter I have shown how mindfulness-based therapies have been introduced 
within clinical psychology over the past 30 to 40 years and there development within 
the cognitive-behavioural tradition. Their origins go back much further, to meditative 
traditions dating back thousands of years. Taken as a whole, these therapies aim to 
alter the relationship with difficult inner experience to alleviate the distress these 
experiences cause. One way of conceptualising these therapies is by grouping them 
according to how whether mindfulness is a major or a minor component of the 
therapy. There is a growing evidence base for these therapies however reviews of 
these therapies have not comprehensively summarised their effectiveness. My aim is 
to contribute to this evidence base and inform practice, by conducting a meta-
analysis of these therapies. 
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2. Methods 
2.1 Chapter outline 
Before conducting a meta-analysis, there are a number of essential stages which 
need to be carefully conducted. These lend methodological rigour to the analysis and 
support conclusions drawn from it. These stages include a comprehensive search of 
the literature, so that all relevant studies are included; and the strict application of 
eligibility criteria. Finally consideration is given to relevant methodological and data 
issues in conducting a meta-analysis. 
 
2.2 Systematic literature search 
Two databases were searched and the details are presented in Table 2. PsycINFO® 
is an electronic abstract database and possibly the leading source of abstracts in the 
psychological literature. It is compiled by the American Psychological Association and 
has over 2.6 million records (APA, 2009), with records dating back to the 1800s. 
PsycINFO® is updated weekly and includes journal articles (over 2150 titles, which 
make up the majority of records) as well as book chapters. 
 
MEDLINE® is the leading electronic bibliographic database of articles in the life 
sciences and biomedical fields. It is compiled by the National Library of Medicine in 
the United States and has over 16 million records from over 5200 journals (NLM, 
2009) with weekly updates. The main coverage is from 1949 onwards. 
 
Table 2. Details of databases searched 
Database Source Date range of search Date search 
conducted 
PsycINFO® Ovid SP 1967-January Week 1 2009 09/01/2009 
MEDLINE® PubMed 1967-January Week 1 2009 10/01/2009 
 
Comprehensive search strategies were developed to be run on these databases 
services to ensure relevant studies were identified. These search strategies 
(see 6.3.1) employed searching of text words and index terms. The extent of a text 
word search depended on the database and could include words or phrases in the 
title of the article, the abstract, the key concepts supplied by the authors or journal, or 
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the table of contents. Index terms, such as MeSH terms in Medline, were added 
when the citation was added to the database. 
 
These strategies comprised of two components: to find 1) relevant therapies, and 2) 
appropriate study designs. The first component of the search strategies looked at 
mindfulness-based therapies (MBT) and searched for the names of the therapies as 
a text word. Examples included, “mindfulness”, “MBCT” and “MBSR”. These 
therapies generally did not have terms in the index therefore this component relied on 
this text word searching. An exception was that “mindfulness” was an indexed term in 
the psycINFO® database. 
 
The second part of the strategy was used to identify appropriate study designs. 
Indexing of study designs was more advanced on the databases and this component 
of the search could employ these indexing systems. However this relies on accurate 
coding by the database and so this component of the search did not rely entirely on 
the indexing system and also used text words. For example, “clinical trial” was 
searched for as an index term and as a text word. 
 
The search strategies then combined these two components. Citations found were 
retrieved if they contained an appropriate therapy term AND an appropriate 
methodology term or keyword. The search strategy aimed to find: 
• all experimental studies; 
• of any type of therapy with a mindfulness component. 
 
The search strategies were developed with reference to that employed by the 
specialised trial register search of the Cochrane Collaboration Depression, Anxiety 
and Neurosis Group strategy (Churchill, et al., 2009). All retrieved studies were 
added to and managed within Endnote® bibliographic database software 
(version X2). 
 
At this stage of a systematic review sensitivity is more important than specificity. It 
was more important to cast the net wide and risk finding more studies in the search 
which are not eligible; that is to have a high false-positive rate. The alternative was 
less desirable; that is to not find studies which would be included in the review and 
have a high false-negative rate. 
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Additionally, “snowball” methods (Greenhalgh & Peacock, 2005) were used. These 
included scanning the reference lists of potential studies and published reviews to 
identify further references. 
 
2.2.1 Number of citations identified 
A total of 687 citations were identified in these searches. 89 of these citations (13% of 
those identified) were duplicates, where the same article was retrieved from both of 
the databases, and were removed. Most of these duplicates were identified by the 
Endnote® software however some were identified by hand. These were typically 
where the journal title was abbreviated in one citation but written in full in the other. 
 
598 unique citations were identified through the search strategy and were screened. 
These figures are detailed in the flow diagram below (Figure 4), which also shows the 
other stages of the study selection procedure. 
 
2.3 Screening 
The initial screening involved reading the abstracts – or title only if no abstract was 
available - of identified citations to determine whether they could possibly meet the 
eligibility criteria. This represented a broad screen of the identified studies and it was 
anticipated that this would remove a considerable proportion because of the broad 
search criteria. The aim was to confirm - where possible - that citations were of: 
• An experimental study; 
• of any type of therapy with a mindfulness component; 
• for any type of psychological condition; and 
• treating a population commonly seen within mental health services. 
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Figure 4. Flow diagram of study selection procedure 
 
 
Citations identified through 
database searching 
n = 687 
Number of duplicate 
citations removed 
n = 89 
Citations screened 
n = 598 
Articles assessed for 
eligibility 
n = 113 
Articles excluded n = 73 
Diagnosis unclear (n = 3) 
Intervention (n = 3) 
Language (n = 2) 
Outcomes (n = 2) 
Participants (n = 54) 
Publication type (n = 1) 
Study design (n = 6) 
 
Data inappropriate (n = 1) 
No study reported (n = 1) 
Included in meta-analysis 
study pool 
n = 40 
Identification 
Screening 
Eligibility 
Inclusion 
Number of citations removed 
n = 485 
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Two researchers (RM and SW) completed an initial screening separately. A form was 
designed for this purpose which listed the citations (see 6.3.2) and a separate file 
used which detailed the citation and abstract. The electronic versions of these were 
used. All studies were given a reference number at this stage to facilitate the process. 
For studies to be retrieved both researchers had to agree. An attempt to reconcile 
differences of opinion was made through discussion until a consensus was reached. 
If a consensus could not be reached then a third researcher (AG) arbitrated. As these 
data were held electronically they were easily exported into an Excel® spreadsheet to 
manage the process of reconciliation through the use of the formulas available within 
Excel. 
 
Categories used in this initial screening were either YES (retrieve and assess for 
eligibility) or NO (do not retrieve). Additionally, systematic reviews were flagged up to 
enable a hand search of their reference lists (note that these were indicated as 
excluded articles). 
 
2.3.1 Number of studies identified in the screening 
Of the 598 citations screened, there was an initial agreement between the two 
reviewers for 547 of these citations (of which, 90 were to be retrieved and 457 
excluded). Of the remaining contested 51 citations, consensus was reached at a 
meeting without resort to a third-party. It was agreed to retrieve 22 further studies 
from this 51 and exclude 29. 
 
Overall, it was agreed to exclude 485 studies at this stage and advanced 113 to be 
assessed for eligibility (see Figure 4). The number of studies excluded at this stage 
was therefore considerable and represented 81% (485 of 598) of the citations 
entered into the process. This was expected because the initial search strategy was 
intentionally broad and so for example included many discussion articles which did 
not feature original study data. The information presented within the title and abstract 
was limited and if there was any doubt over the content of the article it was retrieved. 
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2.4 Eligibility 
The next stage involved the application of the eligibility criteria to the studies. Copies 
of all of the 113 articles were retrieved to enable this. These were obtained from 
either the University of Hertfordshire’s Learning Resource Centre (LRC); through the 
LRC Inter Library Loans facility; or through email contact with the authors. 
 
A form was designed and completed electronically to record the eligibility 
assessment (see 6.3.3). Two researchers (RM and SW) each conducted this stage 
and their respective decisions were compared, again using formulas within Excel®. 
The completed forms allowed the reviewers to detail the reason for exclusion, to 
allow discussion of differences of opinion and ultimately to detail these reasons (see 
Figure 4). These were discussed and where a consensus could not be agreed, a third 
reviewer (JS) reconciled these differences. German language articles were assessed 
for eligibility by one reviewer (JS). 
 
At this stage linked papers, where two or more papers reporting on the results of one 
study, were flagged up. This could include, for example, a paper reporting additional 
follow-up data from an earlier study. 
 
2.4.1 Eligibility criteria 
2.4.1.1 Language 
The review included studies published in either English or German only as we were 
limited to the languages members of the project team were proficient in. Where 
potential studies were identified that were published in other languages, an author 
was contacted to determine whether an English translation of the article existed. 
 
2.4.1.2 Publication type 
Dissertations were not included in the review. To have included dissertations would 
have required manuscripts to be obtained from authors or other institution’s libraries. 
It was anticipated that this would involve considerable resources and would not 
necessarily be possible within the time scale of this study. Furthermore it was 
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anticipated that at least some of these studies were subsequently reported in peer-
reviewed journals. 
All other types of publication were considered and it was anticipated that the majority 
of studies would be published in peer-reviewed journal articles and book chapters. 
 
2.4.1.3 Study design 
Studies that employed an experimental (interventional) research design were 
included. The following types of trials were included: 
1. Randomised Controlled Trials (RCT) 
2. Quasi-Randomised Controlled Trials (QRCT) 
3. Non-Randomised Controlled Trials (NRCT) 
4. Uncontrolled Trials (UT) 
 
Other non-randomised experimental designs were also considered for inclusion. This 
included designs described as for example one-group post-test only; one-group pre-
test post-test; non-equivalent groups post-test only; and non-equivalent groups pre-
test post-test (Barker, et al., 2002). 
 
Other types of studies which included pre-post designs - but perhaps more accurately 
described as ‘audits’ - were also included. It was possible to obtain an effect size for 
relevant outcome variables for these studies and so include them in the analysis. 
Furthermore and more importantly, they represented effectiveness research as they 
were all conducted in typical clinical settings. While these studies may compromise 
their internal validity, they maximise their external validity. They will more accurately 
reflect usual clinical settings in terms of for example the competence and experience 
of the therapists or the selection of participants. 
 
Individual case studies and reports or other forms of anecdotal research were 
excluded. Single case designs were excluded and an example of these designs was 
described as (non-concurrent) multiple baseline across participants design. 
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2.4.1.4 Participants 
In the present study I was interested in the overarching question, “as a clinical 
psychologist, could Mindfulness-Based Therapies (MBT) help me in my routine 
clinical work within a mental health setting?” The focus therefore was on Axis 1 
disorders within the DSM-IV framework (American Psychiatric Association, 2000) and 
therefore personality and other Axis 2 developmental disorders were excluded. 
 
Studies investigating MBT for any psychological condition were therefore included, 
where a formal diagnosis was explicitly stated and defined using appropriate criteria 
(which was acceptable at the time of publication of the study). Psychological 
conditions of any severity and chronicity were considered for inclusion, where the 
population was a clinical sample. 
 
Studies where the primary diagnosis was a physical condition were excluded even if 
they investigated psychological outcomes. It was acknowledged that an important 
area of clinical psychology work was that conducted within physical health settings; 
however these were considered beyond the scope of this study. Furthermore, as I 
was approaching it from a mental health perspective my primary interest was in 
psychological conditions. Within the physical health setting the primary condition will 
often remain following treatment and it is possible that the mechanism of action – or 
at the very least the intention behind therapy - may be different. 
 
Studies investigating treatments for substance misuse or withdrawal of any type (for 
example alcohol, nicotine and banned substances) were not included. Often clinical 
psychologists tend only to be involved working with these clients within specialist 
services and if the misuse forms part of a dual diagnosis. Again in these settings the 
intention behind therapy may be different. Some studies may look at, for example, 
reducing anxiety symptomatology. However this would again represent a grey area 
where it could potentially be difficult to clearly differentiate the aims of the research. 
 
Studies involving people with learning disabilities were not included as typically they 
are seen within more specialist services. There are some studies implementing and 
assessing the role of mindfulness within LD services, however problems encountered 
with people with LD may have very different aetiologies and furthermore, the 
mindfulness techniques may need to be adapted considerably. 
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In summary these populations raise interesting questions about the applicability of 
MBT which subsequent research should address. However they fall outside the 
scope of this review. I was interested in studies for which it was clear that the primary 
diagnosis was psychological and the work was typical of general mental health 
services. 
 
2.4.1.5 Sample size 
Studies of sample sizes greater than five participants were considered for the review. 
 
2.4.1.6 Intervention 
Any type of therapy which included mindfulness was considered for inclusion. 
Mindfulness-based treatment approaches included more recently developed forms, 
such as (but not limited to): 
• ABBT  Acceptance-Based Behaviour Therapy 
• ACT  Acceptance and Commitment Therapy 
• BCP  Buddhist Counselling Programme 
• DBT  Dialectical Behaviour Therapy 
• MAP  Mindful Awareness Practises 
• MBCT  Mindfulness-Based Cognitive Therapy 
• MB-EAT Mindfulness-Based Eating Awareness Training 
• MBPM  Mindfulness-Based Pain Management 
• MBSR  Mindfulness-Based Stress Reduction 
• MBRE  Mindfulness-Based Relationship Enhancement 
• MBRP  Mindfulness-Based Relapse Prevention 
• MBT  Mindfulness-Based Therapy 
• MCT  Meta-Cognitive Therapy 
 
2.4.1.7 Control group 
If applicable, control or comparison groups typically included active (experimental) 
treatments; placebo; waiting-list controls; treatment as usual; no-treatment controls; 
and attention control. 
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2.4.1.8 Observation period 
Studies were included if the duration of treatment – that is the mindfulness 
intervention - was of one week’s duration or longer. Follow-up needed to occur at 
either the end of treatment or after the treatment had finished. 
 
2.4.1.9 Outcomes 
Studies were included with at least one outcome measuring subjective change in 
symptomatology. All additional outcome measures of any type of objective or 
subjective parameter were included. All scales used needed to be validated and 
reliable. It was anticipated that these outcomes would include subjective as well as 
objective measures such as: 
• Disease-specific measures of functioning; 
• Treatment-specific measures of outcome; 
• Generic measures of functioning (e.g. general health); 
• Quality of life measures; 
• Physiological markers. 
 
Side effects and the acceptability of treatments (as measured by withdrawals) were 
not considered. 
 
2.4.2 Number of eligible studies 
113 articles were retrieved and assessed for inclusion and a total of 40 studies (35% 
of those assessed) met the inclusion criteria. These studies formed the ‘pool’ from 
which studies were drawn for the meta-analysis. This number represents 6% of those 
initially identified. 
 
A total of 73 studies were excluded and the reasons were detailed in Figure 4. Most 
of these studies (74% of the exclusions; n = 54) were excluded because of the 
sample. Within this category the majority of studies were of DBT where the 
participants were diagnosed with Borderline Personality Disorder (an Axis 2 condition 
within DSM-IV). 
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2.5 Data extraction and coding 
When the list of included studies was finalised relevant data were extracted. These 
tables summarised details of the study and the first table detailed general information 
and the second outcome data. Only the studies actually used in the analysis are 
detailed in these tables in the appendix (6.4). The variables used in the analysis were 
listed below and where relevant, the coding categories or units used in the analysis 
were provided. 
 
• Study design 
o Randomised Controlled Trial 
o Two groups (not randomised) 
o Single group (pre- and post) 
o Audit 
• Duration of therapy and follow-up (weeks) 
• Diagnostic category 
o Anxiety 
o Depression 
o Attention Deficit and Hyperactivity Disorder (ADHD) 
o Eating disorder 
• Diagnosis (including criteria used) 
• Total number of participants, by group 
• Mean age of sample 
• Percentage of females in study population 
• Intervention and whether mindfulness was a major or minor component 
o Major component therapies included: 
 Mindful Awareness Practices (MAP) 
 Mindfulness-Based Cognitive Therapy (MBCT) 
 Mindfulness-Based Eating Awareness Training (MB-EAT) 
 Mindfulness-Based Stress Reduction (MBSR) 
o Minor component therapies included: 
 Acceptance-Based Behaviour Therapy (ABBT) 
 Acceptance and Commitment Therapy (ACT) 
 Buddhist Counselling Programme (BCP) 
 Meta-Cognitive Therapy (MCT) 
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• Therapy format 
o group 
o individual 
• Number and duration (hours) of sessions 
• Number of therapists and whether training detailed (yes/no) 
• Control group(s) 
o None 
o Waiting List (WL) 
o Treatment as Usual (TAU) 
o maintenance Antidepressant Medication (a ADM) 
 
Outcome measures were recorded separately, which included the time-point of the 
measurement (pre- or post-treatment; or follow-up). Where given, means and 
standard deviations (SD) were recorded to allow for effect sizes to be calculated. 
 
2.6 Methodological and data considerations in meta-analysis 
Meta-analysis is a statistical approach to combining the evidence from a number of 
studies. Through meta-analysis important research questions can be asked of these 
data. However meta-analysis is a science in itself and much consideration needs to 
be given to its method. 
 
2.6.1 Non-randomised designs 
It is the subject of some debate as to whether meta-analysis should include non-
randomised studies. Differences have been found between meta-analysed 
randomised and single-group designs (Ioannidis, et al., 2001; Linde, Scholz, 
Melchart, & Willich, 2002) however these reviews do not consider it inappropriate 
when interpreted with caution. Often the decision was a pragmatic one: if the majority 
of the evidence was comprised of single-group designs then this must form the basis 
of an overview of that evidence. 
 
From the overview of existing systematic reviews (see 1.8.2) it was anticipated that 
there will be a considerable mixture of independent-group randomised, controlled 
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trials; and single-group, pre-test post-test designs. If these are to be included, 
consideration must be given to the statistical methodology. 
 
It is acceptable to combine effect sizes from these different study designs if certain 
statistical considerations are addressed (Morris & DeShon, 2002). Morris and 
DeShon (2002) recommend that this includes that common metrics are used for the 
studies whose effect sizes are combined; so for example the standard deviation of 
change scores was used for all studies rather than this mixed with the standard 
deviation of the baseline score. Secondly, the effect sizes should be comparable 
(homogeneous) in terms of treatment effect. Finally, studies should be weighted to 
account for differences in precision. 
 
2.6.2 Effect sizes 
An effect size is a way of quantifying the effectiveness2 of an intervention. It can be 
calculated and expressed in a number of different ways and one fundamental 
distinction is whether the effect size was standardised or not. 
 
Ideally, the studies included within a meta-analysis will have presented within their 
statistical analyses the correlation coefficient of the scores between time points such 
as pre- and post-treatment. Unfortunately reporting of studies was not always 
comprehensive and this information was often not included in reports. This statistic is 
required to calculate the standard error which was used to weight the effect sizes. In 
cases where the correlation coefficient was not presented an assumption was made 
for its value as there was no agreement on what this value should be (Lipsey & 
Wilson, 2000). For the purpose of this meta-analysis, this value was assumed to be 
0.6; which corresponds to a ‘good’ correlation. 
 
2.6.2.1 Mean reduction score 
For those analyses for which only the intervention group was considered in the effect 
size, and where the exact same scale was considered together, the mean reduction 
score – using the raw scores - was used as the effect size. The mean reduction score 
                                               
2
 The term ‘effectiveness’ in this thesis includes the notion of efficacy as well as effectiveness. 
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is the difference in raw data means between two outcome points, typically pre- and 
post-treatment (Lipsey & Wilson, 2000). As this effect size was employed where the 
same commonly used outcome measure was used across all of the studies an 
unstandardised reduction score such as this has a corresponding clinical meaning. 
An example of this was the Beck Depression Inventory (BDI; A.T. Beck, Steer, Ball, & 
Ranieri, 1996), which was one of the most widely used measures of depression. 
 
The formula for the mean reduction score: 
= M1 – M2 
 
And the calculation for the weight: 
 = 1 / √ (2((SD12 + SD22) / 2)(1 - 0.60) / Nt)2 
 
Where: 
M1 and SD1 the pre-treatment mean and standard deviation 
M2 and SD2 the post-treatment mean and standard deviation 
Nt the number of participants in the treatment group 
 
In those analyses where data for an intervention group and a control group were 
compared the unstandardised reduction score was also used. For each of the 
studies, the raw mean difference in the change scores between the intervention and 
control groups was the effect size. 
 
2.6.2.2 Standardised reduction score 
A large number of rating scales exist for measuring outcome. If all studies included in 
the analysis did not use the same outcome measure they were grouped according to 
the condition being measured. For example, anxiety scales were grouped together. In 
this case the different scales were standardised to allow a direct comparison and the 
effect size used was the standardised reduction score. 
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The formula for the standardised reduction score, with the same notation as used 
above, was: 
= (M1 – M2) / √ ((SD12 + SD22) / 2) 
 
And the calculation for the weight: 
 = ( 2 Nt / (( 4 (1 – 0.60)) + (M1 – M2) / √ ((SD12 + SD22) / 2)2 ) 
 
2.6.2.3 Hedges’ g 
For the analysis which considered the effect size in the intervention group relative to 
the control group, a standardised mean difference was calculated, specifically 
Hedges’ g statistic (Hedges & Olkin, 1985). 
 
The formula for Hedges’ g was: 
g = (Mt – Mc) / Sp 
 
Where: 
Mt = the mean of the treatment group on a specific measure 
Mc = the mean of the comparison group on that measure 
Sp = the pooled estimator for the variances 
 
2.6.3 Fixed, random and mixed effects models 
Fixed and random effects models are different approaches to the calculation of 
overall effect in a meta-analysis, which differ in their assumptions about the 
population(s) the studies are drawn from (Hedges & Vevea, 1998; Hunter & Schmidt, 
2000). Fixed effects models assume the studies are all drawn from the same ‘super’ 
population – and so there will be a one, fixed effect size. Differences between the 
effect sizes in the studies are understood to be due to random variation around this 
fixed effect size. This is contrasted with the random effects model which assumes 
studies are drawn from different populations and so as a result, the effect of the 
intervention within these different populations will vary. 
 
There is considerable debate about the appropriate model to use (Hedges & Vevea, 
1998; Hunter & Schmidt, 2000). The random effects model generally has less 
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precision and so the confidence interval around the estimate tends to be wider – 
which means they are a more conservative test. However its assumptions are more 
realistic for real-world data. As the random effect model assumes populations will 
vary there will also be variability between the studies as well as within-study variation. 
Each study therefore is just a realisation of one sample of the possible distribution of 
studies. However as it was anticipated that the studies will represent a considerable 
range of therapies and conditions, it was highly unlikely that a fixed effects model 
would be appropriate. I think this was a more realistic assumption and do not believe 
these studies can find one true effect size for these therapies. The random effect 
model will therefore be used in my analysis. 
 
I am still interested in explaining further some of the amount of variation between 
studies and will undertake moderator analyses (see 2.6.5). When undertaking a 
moderator analysis the appropriate model is a mixed effects model. This comprises of 
a random effects component – which allows for sampling error and random difference 
between studies – and a fixed effect – which accounts for the variation between 
groups. 
 
2.6.4 Heterogeneity between studies 
The Q-Test is a statistical test originally proposed by Cochran (1954) but more 
commonly associated with DerSimonian and Laird (1986). It is the most commonly 
used method in meta-analysis for assessing for heterogeneity between included 
studies. The basic principle is that similar investigations will have drawn subjects from 
the same population and so will have similar effect sizes. There will be some 
sampling error however if the variation is greater than that expected by this sampling 
error then we can assume statistical heterogeneity. This may be for a number of 
reasons. It is possible that it was a chance finding; it also may be due to the scale 
used to measure treatment effect or it is a characteristic of the design of the study. 
The other option is that it was due to a study characteristic which can be investigated 
as a possible moderator variable. 
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2.6.5 Moderators of effect 
A number of theories have been offered as to how MBT work therapeutically, such as 
the work of Brown and Ryan (2003); Shapiro (2006); and Wells (2005). However 
these theories are not currently empirically supported and it is not clear how MBT is 
effective (Lazar, 2005). 
 
Detailed sub-group analyses of reported data from experimental research may help 
inform theory by suggesting possible moderators of effect. For example, certain 
participants may have a greater response to treatment. Or, participants may have a 
greater response to certain forms of the therapy which place greater emphasis on 
certain components. While appropriate analysis of published data would not confirm a 
mechanism of therapeutic action it may provide evidence of association. This 
evidence may then inform subsequent research and development of MBT. I detail 
below some important variables for which it would be useful to consider a moderating 
effect. The ability to conduct analysis with these variables will depend on available 
data. 
 
2.6.5.1 Type of intervention 
There is interest in considering these therapies as having a considerable common 
ground (Baer, 2003) however it would be interesting to test this hypothesis empirically 
by contrasting the effectiveness of these therapies. Some of these therapies often 
have considerable other components and it is possible that these act synergistically 
with the mindfulness component. 
 
There seems to be considerable variation in the proportion that the mindfulness 
component makes within these therapies. It has long been suggested that common 
factors are responsible for the observed effect in psychological therapies 
(Rosenzweig, 1936) and recent research has supported this view (Wampold, 2001; 
Wampold, et al., 1997). It would be interesting to determine whether mindfulness was 
an ‘active ingredient’. This could be investigated by determining whether the 
proportion of the mindfulness component was in any way correlated with outcome. 
One way of undertaking such an analysis was to consider studies as having 
mindfulness as either a ‘minor’ or a ‘major’ component. 
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2.6.5.2 Design of study 
It was likely that the existing literature consisted of a number of different study 
designs. These designs are all useful and often emphasise either internal or external 
validity at the expense of the other. However a comparison of these study designs 
and the effect sizes they produce would usefully address questions relating to the 
effectiveness of these therapies in the real world. 
 
2.6.5.3 Gender 
Early research has considered the link between gender and frequency of meditation 
practise (Delmonte, 1984) and found no relationship. However mindfulness has 
developed considerably and it is unclear whether these approaches are particularly 
suited to particular demographics within the population. Gender is generally a clearly 
detailed variable within study reports and so a preliminary investigation could include 
these details. 
 
2.6.5.4 Therapist training 
Baer (Baer, 2006) gives a good overview of the training requirements for the various 
therapies. In general, while some of the more established therapies have bodies 
which recommended standards for training, they generally cannot be enforced. This 
situation may change however as therapies develop and become more widely 
recognised. Professionally registered therapists however will have general training 
and practice standards covered by their profession. In the UK for example, the 
professional standards set out by the British Psychological Society will hopefully 
ensure an adequate level of expertise before practising. 
 
There are a number of studies which have looked at therapist training and its effect 
on outcome (Allen, et al., 2006; Ludwig Grepmair, Mitterlehner, Loew, Bachler, et al., 
2007; Ludwig Grepmair, Mitterlehner, Loew, & Nickel, 2007; L. Grepmair, 
Mitterlehner, & Nickel, 2008; Ludwig Grepmair, Mitterlehner, Rother, & Nickel, 2006; 
Schmidt, 2004; S. L. Shapiro, Brown, & Biegel, 2007; Stanley, et al., 2006). These 
studies generally find a therapist’s personal training and practise as beneficial to 
clients. 
 
Thesis Page 61 
2.6.5.5 Type of psychological condition 
Some MBT were designed for specific client groups, for example MBCT was 
developed for the prevention of relapse in recurrent depression. However more 
recently there has been interest in a wider application of this therapy to other 
conditions. 
 
2.6.5.6 Age 
There was some evidence from investigations into meditation practice that age may 
play a factor in maintenance of practice; however it was unclear how. One study 
found more benefit with older clients (Delmonte, 1980). However these findings were 
contradicted in another study by the same author (Delmonte, 1986), which found that 
older subjects showed less improvement and meditated less often. It would be useful 
to clarify whether there was a link. 
 
2.6.6 Publication bias 
Publication bias is a common concern when conducting meta-analysis. This is where 
it is recognised that the studies available for - and so included within - a meta-
analysis are a select sample, chosen on the basis of their positive effect (Dickersin, 
1990). Negative (or inconclusive) studies are less likely to be published either 
because researchers are less likely to write up and submit negative studies, or 
editors are less likely to accept them for publication. If studies are published on the 
strength of their findings then it is likely that those not included in a meta-analysis will 
have different results and this will introduce significant bias to the analysis. 
 
2.6.6.1 Funnel plots 
One common method of investigating whether publication bias has been introduced 
is through the use of a funnel plot (Light & Pilemer, 1984). This plots effect size 
against a measure of the study sample size. A central line indicates the mean effect 
size and the pattern the data points make around this line can provide useful 
information. The assumption is that when the sample size is low there will be less 
precision and so studies will scatter more widely (and randomly) around the mean. 
Studies with larger sample sizes will have more precision and so will scatter less 
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widely around the mean, leading to a distinct funnel-shaped graph (see Figure 5). 
When the plot is asymmetric (Figure 5) it may indicate the existence of publication 
bias because insignificant results from small studies were not published. 
 
 
Figure 5. Funnel plots showing symmetrical and asymmetrical distributions 
 
2.6.6.2 Fail safe N 
Unpublished studies may have influenced the effect size and the ‘fail safe N’ is a 
calculation to determine how robust the findings are in light of this. Developed by 
Rosenthal (1979), it provided an estimate of the number of non-significant studies 
required to render the effect size non-significant (in its original form). One criticism of 
the original method is that it focuses on p values (the number of studies required to 
render the finding non-significant) rather than the size of the effect. However it is 
useful if considered carefully and an alternative to Rosenthal’s original method was 
developed by Orwin (1983) and was used in this study, which determines the number 
of studies required to render the size of the effect negligible rather than zero. 
 
Sample Size 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* * 
* * 
Effect Size 
Sample Size 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* * 
Effect Size 
Symmetrical Asymmetrical 
Thesis Page 63 
2.7 Data analysis 
Where applicable, reporting of the meta-analysis reflected the appropriate guidelines. 
For example the current QUORUM (Quality of Reporting of Meta-Analyses) 
guidelines for RCTs (Moher, et al., 1999). Although unpublished at the time of writing, 
reference was made to the updated PRISMA (Preferred Reporting Items for 
Systematic reviews and Meta-Analyses) guidelines for all healthcare interventions 
and study designs. The main data analysis was conducted within SPSS® (SPSS Inc, 
15/11/2007). Extensive use was made of SPSS® meta-analysis macros (Lipsey & 
Wilson, 2000). Some additional analyses were performed in MIX (Bax, Yu, Ikeda, 
Tsuruta, & Moons, April 2008). 
 
Generally data were presented to two decimal places, however there were some 
exceptions. Firstly where studies presented data to a lesser degree of precision this 
was reproduced: for example, to one decimal place. This was to avoid suggesting a 
higher degree of precision than was reported. Secondly, where a greater degree of 
precision was a more useful statistic this was reported; for example with probability 
(p) values. Finally, where the statistical package provided data to a lesser degree of 
precision this was presented. 
 
The meta-analysis used summary statistics reported in each study. If effect sizes 
were provided these were not used but recalculated for the analysis. Where possible, 
data from Intention to Treat (ITT) analysis was used. Pre-treatment was defined as 
latest available assessment prior to treatment. Post-treatment was defined as those 
data points closest to the final treatment session. 
 
If means and SD were not presented where possible they were calculated or 
estimated from available data. For example, estimated from the median and range 
(Hozo, Djulbegovic, & Hozo, 2005); calculated from the SD and 95% confidence 
interval; or calculated from Cohen’s d and the raw difference score. 
 
Effect size and change scores were presented so a positive value indicated an 
improvement. 
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2.7.1.1 Forest plots 
A forest plot is a distinct form of error-bar chart frequently used in meta-analysis. It is 
used to group the relative effect sizes of studies as well as the combined effect size 
into one chart. Typically the effect sizes of the component studies are indicated by a 
square, the size of which is determined by the relative weight (or contribution the 
study makes to the overall effect size. The overall effect size is indicated by a 
diamond. For all of the effect sizes, the confidence interval is represented by an error 
bar. The line of no effect (zero) is usually added as a reference line. Where 
applicable, forest plots will be used to illustrate the meta-analyses. 
 
2.8 Chapter summary 
There were a number of important stages completed before the meta-analysis was 
conducted, which together formed a systematic search of the literature. The first 
stage involved developing and running a comprehensive search strategy to identify 
possible studies for the analysis. Once identified, citations were screened. This 
screening stage involved reading the citations and abstracts of these articles. Those 
reporting studies which were deemed potentially suitable for the meta-analysis were 
retrieved and included in the next stage of the process. This involved reading the full 
article and applying the eligibility criteria to each of the studies. Eligible articles were 
included in the pool of studies for the meta-analysis. To enable the analysis, relevant 
data were extracted from the articles and entered onto the study database. Finally 
some methodological considerations of the data analysis were presented. 
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3. Results 
3.1 Chapter outline 
The results of my analyses are provided in this chapter and are presented in three 
main sections. These sections in turn consider therapies with mindfulness as a major 
component; therapies with mindfulness as a minor component; and finally a 
comparison of these two groups of therapies. The main analyses calculate effect 
sizes for the combined studies and consider the likelihood of publication bias. Where 
possible, moderator analyses were conducted to attempt to explain some of the 
observed heterogeneity between studies. 
 
 
3.2 The study pool 
A total of 40 studies were included within the study pool and once this pool was 
formed, it was possible to determine the precise analyses conducted. The analyses 
were therefore guided by the available data and this resulted in three main analyses 
which are detailed in this chapter and summarised in Figure 6. Until this stage was 
reached it was not possible to determine whether an analysis of for example follow-
up data as well as pre- to post-treatment was possible. Unfortunately very few studies 
reported follow-up data and for those that did there was considerable variation in the 
time point. Some studies reported three-month follow-up data whereas others 
reported one-year. All analyses were based on change from pre- to post-treatment 
and one study – Miller (1995) - was excluded at this stage as it only reported three-
year follow-up data from a previous trial, Kabat-Zinn (1992). It was not possible to 
combine these data meaningfully with data from other studies. 
 
The other 19 studies which were rendered ineligible for the analyses presented a 
considerable range of outcome measures. I needed to create reasonably sized 
groups of studies with a meaningful number to warrant meta-analysis and more detail 
was provided in each section. It was not possible to include these 19 studies in any of 
these three analyses. For example condition-specific outcomes only were presented; 
or objective outcomes across a small number of studies. One notable group of 
studies excluded at this stage was the three important early studies of Mindfulness-
Based Cognitive Therapy. These only presented data on relapse - Teasdale (2000) 
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and Ma (2004) - or change in a unique outcome related to memory - Williams (2000), 
which was a further report on data from Teasdale (2000). Unfortunately this meant 
they could not be combined with other data. 
 
A total of 21 studies were included in the meta-analysis. These were formed into 
three main groups that looked at studies for which mindfulness was considered a 
major component of the therapy (k = 11); where mindfulness was considered a minor 
component of the therapy (k = 8); and a comparison of these two groups of therapies 
(k = 12). Note that some studies were included in more than one of these three 
analyses. 
 
3.3 Mindfulness as a major component of therapy 
This part of the meta-analysis aimed to answer the question: 
“Are therapies for which mindfulness forms a major component of the 
intervention effective in treating psychological conditions?” 
 
With reference to the introduction (see 1.5), the distinguishing feature of these 
mindfulness-based practices was that the mainstay of the therapy was the 
mindfulness technique and its practise. Interventions within this group included 
Mindfulness-Based Cognitive Therapy (MBCT); Mindfulness-Based Stress Reduction 
(MBSR); Mindful Awareness Practices (MAP); and Mindfulness-Based Eating 
Awareness Training (MB-EAT). 
 
A total of 11 studies were included in this part of the analysis and these studies are 
detailed in the Appendix (6.4). Of these studies approximately half were single-group 
pre-post designs (k = 6). 
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Figure 6. Flow diagram detailing the number of studies included in the analyses 
 
Meta-analysis 
study pool 
n = 40 
Mindfulness as a minor 
component of therapy 
k = 8 
Mindfulness as a major vs. minor 
component of therapy 
k = 12 
Mindfulness as a major 
component of therapy 
k = 11 
Not included (n = 19) 
 
Follow-up data only (n = 1) 
Outcomes (n=18) 
Included 
n = 21 
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This analysis had three main parts. The first part included all of these studies and 
calculated the effect size of a single outcome measure, from pre-treatment to post-
treatment. The use of the Beck Depression Inventory (BDI) at these time points 
determined the studies within this section. This part also investigated possible 
moderators for the effect size observed and included a number of subgroup analyses. 
Then the effect size of controlled studies with the same outcome measure only was 
determined in the third part, and the moderator analysis continued with a comparison 
of controlled and uncontrolled studies. Finally, the effect size was determined for 
those studies which provided data on the Beck Anxiety Inventory (BAI) pre-treatment 
and post-treatment. 
 
3.3.1 Reduction in Beck Depression Inventory (BDI) scores 
In this analysis the total number of studies (k) included was 11. The details of these 
studies relevant to the meta-analysis were summarised in Table 3. The total number 
of participants (N) was 327 participants were analysed: this figure comprises of the 
total number of analysed participants across the studies, within the treatment groups. 
MBCT was the most commonly investigated treatment (k = 7); other treatments 
included MBSR (k = 2); MAP (k = 1); and MB-EAT (k = 1). 
 
Approximately two-thirds of these studies (k = 7) treated depression as the index 
condition; two treated anxiety; and one study treated Attention Deficit and 
Hyperactivity Disorder (ADHD) and one eating disorder. All of the treatments used in 
these studies were group interventions. Most of the studies had an initial treatment 
period of eight sessions over eight weeks (k = 10). The exceptions were 
Kuyken (2008) which had the initial eight-week course followed by four additional 
sessions over the course of a year; and Kristeller (1999), which was a six-week 
course. Note that in Kuyken (2008) post-treatment assessment was prior to these 
additional sessions and so for the purpose of the pre- to post-treatment analysis, the 
duration of treatment in Kuyken (2008) was equivalent to eight weeks. 
 
Nine of the eleven studies detailed the mean age within their sample. These studies 
had participants with a mean age that ranged from 38.0 years to 50.2 years. Of the 
studies that did not report the means Eisendrath (2008) was a brief ‘letter to the 
editor’ which reported the age range of the sample only (22-75 years); and similarly 
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Williams (2008) was a brief report which detailed the inclusion criterion of the range 
(18-65 years) and that the two groups were comparable with regard to age. Ten of 
the eleven studies reported the numbers of males and females apart from 
Williams (2008) which again reported no statistically significant difference in gender 
numbers between the groups. For the studies reporting gender numbers the 
percentage of females ranged from approximately half of the sample (54.5%) to the 
whole sample (100%). Kristeller (1999) purposely recruited females only. 
Approximately half of the studies (k = 6) reported the training undergone by the 
therapists within the study. 
 
Table 4 summarises the BDI scores within the individual studies. Pre-treatment mean 
BDI scores ranged from 13.8 with a standard deviation (SD) of 7.9, which was on the 
borderline for mild depression (range for mild depression was 14-19). This mean was 
in Evans (2008) – for which anxiety was the index condition for the participants of the 
study. The maximum pre-treatment BDI score was 35.73 (SD = 8.69) in 
Finucane (2006). This was in the range for severe depression (for which the range 
was 29-63). 
 
Since all studies in Table 4 used the BDI, the pre- to post-treatment raw mean 
difference was used as an effect size representing the average reduction over the 
course of therapy (that is the mean reduction score = Meanpre – Meanpost). All of the 
studies have used the BDI-II apart from Kabat-Zinn (1992), which used the BDI. 
 
Unfortunately only one of these studies - Eisendrath (2008) - reported the value of the 
pre-post correlation. The pre- post-correlation was however, required for each study 
in the formula for estimating an overall mean reduction score, where it is used to 
weight each study (see Lipsey & Wilson, 2002, p. 42). The weights in Table 4 were 
therefore calculated assuming a modest pre-post correlation of the BDI scores of 
r = 0.6 which allows considerable differences in the individual responses to therapy. 
All of the studies reported a significant (p  < 0.05) reduction in the BDI scores. 
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Table 3. Major component studies included in meta-analysis of the mean reduction in BDI scores, pre- and post-treatment 
Lead author (year) Design Intervention* Diagnostic group 
Treatment 
duration, 
weeks 
Treatment 
group 
number 
analysed 
Mean 
age 
Percentage 
female 
Therapist 
training 
detailed 
Eisendrath (2008) Pre-post single group MBCT Depression 8 51 -- 74.5 No 
Evans (2008) Pre-post single group MBCT Anxiety 8 11 49.0 54.5 Yes 
Finucane (2006) Pre-post single group MBCT Depression 8 13 43.0 90.9 Yes 
Kabat-Zinn (1992) Pre-post single group MBSR Anxiety 8 22 38.0 72.3 Yes 
Kenny (2007) Audit MBCT Depression 8 79 43.3 74.0 No 
Kingston (2007) Pre-post two groups MBCT Depression 8 8 41.8 89.5 No 
Kristeller (1999) Pre-post single group MB-EAT Eating disorder 6 18 46.5 100.0 No 
Kuyken (2008) RCT MBCT Depression 8 (52) 61 49.2 76.4 Yes 
Ramel (2004) Pre-post two groups MBSR Depression 8 11 50.2 45.5 Yes 
Williams (2008) RCT MBCT Depression 8 28 -- -- Yes 
Zylowska (2008) Pre-post single group MAP ADHD 8 25 40.3 62.5 No 
* Interventions were: Mindfulness-Based Cognitive Therapy (MBCT); Mindfulness-Based Stress Reduction (MBSR); Mindful Awareness Practices (MAP); and 
Mindfulness-Based Eating Awareness Training (MB-EAT). 
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Table 4. Effect sizes for the individual studies, BDI pre- to post-treatment 
Lead author 
(year) 
Pre-treatment 
Mean (SD) 
Post- treatment 
Mean (SD) 
Effect size* SE† Weight 
Eisendrath (2008) 23.95 (10.0) 14.6 (9.28) 9.35 1.21 0.69 
Evans (2008) 13.8 (7.9) 8.82 (8.5) 4.98 2.21 0.20 
Finucane (2006) 35.73 (8.69) 17.82 (14.59) 17.91 2.98 0.11 
Kabat-Zinn (1992) 16.47 (10.97) 10 (9.58) 6.47 1.96 0.26 
Kenny (2007) 24.3 (9.8) 13.9 (9.7) 10.40 0.98 1.04 
Kingston (2007) 30.33 (7.66) 12.33 (9.72) 18.00 2.77 0.13 
Kristeller (1999) 17.8 (12.51) 8 (6.15) 9.80 2.08 0.23 
Kuyken (2008) 18.51 (10.91) 13.12 (10.85) 5.39 1.25 0.64 
Ramel (2004) 12.54 (10.61) 9.45 (6.73) 3.09 2.40 0.17 
Williams (2008) 15.6 (13.84) 8.7 (11.95) 6.90 2.19 0.21 
Zylowska (2008) 14.9 (11.1) 7.3 (5.2) 7.60 1.55 0.42 
* Mean reduction score 
† Standard Error (SE) 
 
The summary statistics are presented within Table 5 and the pre- and post-treatment 
distributions of the scores are presented graphically in Figure 7. From this the 
positive-skew to the pre-treatment scores was apparent. However this can still be 
considered approximately normal as from Table 5 we can determine that the 
skewness statistic was less than twice the value of the standard error of skewness. 
 
Table 5. Descriptive statistics for the BDI means of the included studies (k = 11, 
N = 327) 
Statistic Pre-treatment Post-treatment 
Unweighted mean 20.36 11.28 
Unweighted SD 7.39 3.31 
Median 17.80 10.00 
Skewness (SE) 1.10 (0.66) 0.69 (0.66) 
 
Thesis Page 72 
 
Figure 7. Box plot, pre- and post-treatment mean BDI scores (k = 11) 
 
Descriptive statistics for the effect sizes are presented in Table 6 and shown 
graphically in Figure 8. 
 
Table 6. Descriptive statistics for mean reduction score in BDI, pre- and post-
treatment 
Statistic Value 
Unweighted mean 9.08 
Unweighted SD 3.20 
Median 7.60 
Skewness (SE) 1.08 (0.66) 
 
There are two outliers within this distribution, Finucane (2006) and Kingston (2007). 
In comparison to the other studies, these two studies treated severely depressed 
patients with very high pre-treatment depression scores (see Table 3) and thus had 
potentially the largest scope for a reduction in the depression scores if therapy was 
effective. MBCT was originally developed as an intervention to prevent relapse in 
depression however more recently interest has focused on its effectiveness within 
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actively depressed populations. Table 4 shows the pre-treatment BDI means for 
these studies to be both over 30 – indicating severe depression – and so a larger 
change was possible within both of these studies. 
 
 
Figure 8. Box plot of unstandardised reduction score of BDI, pre- to post-treatment 
 
Table 7 provides the mean reduction in score as a percentage of pre-treatment mean 
score. These reductions are based on the means for all participants within the 
studies. The reductions range from 25% to 59% of the pre-treatment scores. 
Spearman’s correlation coefficient of the pre-treatment BDI score and the reduction 
from pre- to post-treatment was highly significant (ρ = 0.845; p = 0.001). 
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Table 7. Percentage reduction pre-treatment to post-treatment in BDI scores, major 
component therapies 
Lead author (year) Pre-treatment Mean Percentage reduction 
Eisendrath (2008) 23.95  39% 
Evans (2008) 13.8  36% 
Finucane (2006) 35.73  50% 
Kabat-Zinn (1992) 16.47  39% 
Kenny (2007) 24.3  43% 
Kingston (2007) 30.33  59% 
Kristeller (1999) 17.8  55% 
Kuyken (2008) 18.51  29% 
Ramel (2004) 12.54  25% 
Williams (2008) 15.6  44% 
Zylowska (2008) 14.9  51% 
 
Figure 9 shows a funnel plot with a symmetrical distribution around the mean effect 
size. This suggests publication bias was unlikely for this analysis. As a further 
estimate to determine the effect unpublished studies may have the fail safe N was 
calculated using Orwin’s method (Orwin, 1983). This found that 37 ‘hidden’ studies 
reporting a zero reduction in the BDI scores were required to bring down the 
observed effect sizes of an average reduction of 8.73 points to a very small effect 
size of just 2 points on the BDI. As it was unlikely that such a large number of 
unpublished studies exist this value would suggest publication bias was unlikely to 
nullify my result. 
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Figure 9. Funnel plot of unstandardised effect size for BDI, pre- to post-treatment 
 
The meta-analysis for this group of studies was reported in Table 8 and the forest plot 
presented in Figure 10. The analysis was conducted with a random effects model, 
which calculated an unstandardised reduction in BDI score of 8.73 (95% CI = LL 
6.61, UL 10.86; p < 0.000). 
 
Table 8. Results of meta-analysis of BDI, pre- and post-treatment 
Comparison k N Combined Effect Size 
95% CI 
(LL, UL)* 
Combined 
z score 
Combined 
p value 
Major component, 
depression (BDI) 11 327 8.73 6.61, 10.86 8.05 0.000 
* 95% Confidence Interval (Lower Limit, Upper Limit) 
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Mindfulness-based Therapy Weight Histogram Mean reduction score
Study ID Year Mean reduction score / SE (%) of w eights with 95% CI
Eisendrath (2008) 2008 9.35 / 1.21 11.00% |||| 9.35 (6.98  to  11.72)
Evans (2008) 2008 4.98 / 2.21 8.00% | 4.98 (0.65  to  9.31)
Finucane (2006) 2006 17.91 / 2.98 7.00% | 17.91 (12.07  to  23.75)
Kabat-Zinn (1992) 1992 6.47 / 1.96 9.00% | 6.47 (2.63  to  10.31)
Kenny (2007) 2007 10.4 / 0.98 12.00% |||| 10.4 (8.48  to  12.32)
Kingston (2007) 2007 18 / 2.77 7.00% | 18 (12.57  to  23.43)
Kristeller (1999) 1999 9.8 / 2.08 9.00% | 9.8 (5.72  to  13.88)
Kuyken (2008) 2008 5.39 / 1.25 11.00% |||| 5.39 (2.94  to  7.84)
Ramel (2004) 2004 3.09 / 2.4 8.00% | 3.09 (-1.61  to  7.79)
Williams (2008) 2008 6.9 / 2.19 8.00% | 6.9 (2.61  to  11.19)
Zylow ska (2008) 2008 7.6 / 1.55 10.00% |||| 7.6 (4.56  to  10.64)
META-ANALYSIS: 100% ||||||||||||||||||||||||||||| 8.73 (6.61 to 10.86)
-5 0 5 10 15 20 25
MD
 
Figure 10. Forest plot of unstandardised mean reduction score in BDI, pre- to post-treatment (k = 11, N = 327) 
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The test for heterogeneity between the studies (Q-Test) was highly significant 
(QT = 42.19, df = 10, p < 0.000), which suggests that the studies were not drawn from 
the same population. This was suggested by outliers in the distribution of the effect 
sizes. This finding suggests the combined effect size should be interpreted with 
caution. The heterogeneity in the effect size distribution between the studies 
indicated that a moderator analysis was justified to identify factors explaining this 
variation. 
 
3.3.2 Moderator analyses 
A number of moderator analyses were conducted to determine whether they could 
explain the variation of the effect sizes in the analysis. These analyses were 
conducted as univariate involving both categorical and continuous moderators (see 
Table 3). The most promising moderators for which data were available were deemed 
to be gender; type of therapy; therapist training; and diagnostic group. 
 
The mean age of participants was reported in nine of the studies and was considered 
as a variable to include in the moderator analysis. However the mean ages covered a 
very small range (Overall mean = 44.6 years; SD = 4.3; range of means = 38.0-50.2) 
and this quite limited variation across the studies rendered it unsuitable. 
 
3.3.2.1 Gender 
Of the 11 studies, ten reported the numbers of male and female participants (see 
Table 3). The number of females was converted to a percentage of the overall 
number of participants within each study. In most studies there was a greater number 
of female participants (mean proportion = 74.0%; SD = 17.8; range = 45.5-100%). 
The distribution was shown graphically in Figure 11. The distribution does not have 
any outliers; all of the data points lie within the inter-quartile range (as represented by 
the ‘whiskers’ on the plot). 
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Figure 11. Box plot showing distribution of percentage females within the studies 
(k = 9) 
 
The unstandardised mean change score was plotted against the percentage of 
females, for each study. The resulting scatterplot shows the linear regression line in 
Figure 12. The dashed line indicates the line of best fit for the correlation. These data 
appear to be well distributed along the line of best fit and there do not appear to be 
any significant outliers in the distribution – this was confirmed with reference to a box 
plot of the distribution (Figure 11). The scatterplot indicates that there was a positive 
correlation between reduction in BDI score and proportion of females. The greater the 
proportion of females taking part in a study, the greater the reported mean reduction 
in BDI score. 
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Figure 12. Scatter plot of reduction in BDI scores and female participants (%) 
 
The moderating effect of gender was investigated with a univariate regression which 
used a mixed effects model. The model was weighted using the inverse of the 
variance for each study. The effect of gender was statistically significant (B = 0.202; 
95% CI LL 0.071, UL 0.333; p = 0.026). In real terms, the unstandardised parameter 
(B = 0.202) means that for every 5% increase in the proportion of females, there was 
an one-point reduction in BDI score. 
 
As this was a simple regression the standardised coefficient was equivalent to 
Pearson’s r = 0.698; indicating a marked degree of correlation (Figure 12). More 
precisely, the regression suggested a considerable amount of the variance was 
associated with gender. The coefficient of determination was r2 = 0.487, meaning 
approximately half (48.7%) of the variation in BDI score was associated with gender. 
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3.3.2.2 Type of therapy 
This analysis determined whether therapy type was an important moderating variable 
in the observed effect. This analysis comprised two groups, comparing MBCT (n = 7) 
with other forms of therapy (n = 4; including MBSR, MB-EAT and MAP). The analysis 
used an inverse variance-weighted mixed effects model. 
 
Table 9 shows the effect sizes for the two groups in the moderator analysis 
separately. The test for between-group differences was not significant (QT = 1.61; 
df = 1; p = 0.205) and furthermore the 95% CIs overlap suggesting that there was no 
significant difference between these two therapy groupings and that this grouping of 
therapies did not explain any of the observed variance in the effect sizes. 
 
Table 9. Effect sizes of therapy groups 
Group k N 
Combined 
Effect 
Size 
95% CI 
(LL, UL) 
Combined 
z score 
Combined p 
value 
MBCT 7 251 9.82 7.06, 12.57 6.99 0.000 
Other 4 76 6.85 3.18, 10.52 3.66 0.000 
 
3.3.2.3 Therapist training 
The second analysis determined whether detailing of therapist training (yes/ no) - was 
an important moderating variable in the observed effect. Reporting on the training 
undergone for the study was used here as a proxy measure for the quality of training: 
if studies do not report these details then the assumption was that this was not an 
important factor when conducting the study. Again, this analysis comprised 11 
studies – yes (k = 6) / no (k = 5). The analysis used an inverse variance-weighted 
one-way random effects ANOVA model. 
 
There was a borderline significant result (QT = 3.35; df = 1; p = 0.065) for therapist 
training. This suggesting that the ‘yes’ group produced a considerably higher mean 
reduction (see Table 10). 
Thesis Page 81 
 
Table 10. Effect sizes of therapist training 
Therapist 
training 
detailed? 
k N Combined Effect Size 
95% CI 
(LL, UL) 
Combined 
z score 
Combined p 
value 
Yes 6 135 6.91 4.24, 9.59 5.07 0.000 
No 5 192 10.47 7.77, 13.17 7.60 0.000 
 
3.3.2.4 Diagnostic group 
This analysis investigated whether diagnostic group (depression vs. other) was an 
important moderating variable in the observed effect. This analysis comprised 11 
studies – depression (k = 7) / other (k = 4; including anxiety, ADHD and eating 
disorders). The analysis used an inverse variance-weighted ANOVA model. 
 
Table 11 shows the effect sizes for the two groups in the moderator analysis 
separately. The test for between-group differences was not significant (QT = 1.01; 
df = 1; p = 0.316) which does not suggest diagnostic grouping was an important 
moderator effect. As the 95% CIs overlap this adds further to there being no 
significant difference between whether the index diagnosis was depression or not. 
 
Table 11. Effect sizes of diagnostic groups 
Group k N 
Combined 
Effect 
Size 
95% CI 
(LL, UL) 
Combined 
z score 
Combined 
p value 
Depression 7 251 9.63 6.81, 12.45 6.69 0.000 
Other 4 76 7.24 3.50, 10.97 3.80 0.000 
 
3.3.3 Reduction in BDI scores for controlled studies 
Of the 11 studies included in this part of the analysis, a total of four used a control 
group. A further analysis of these data involved combining these studies to obtain an 
effect size measure for BDI scores. This was calculated as the unstandardised 
reduction score and also expressed as Hedges’ g. The unstandardised reduction 
score was presented as this gives a sense of the raw change score, as all of the 
studies used the BDI. Information specific to this analysis are provided in Table 12. 
The total number of intervention group participants included in the analysis were 
N = 108; and in the control groups N = 111. There was considerable variation in the 
numbers within each study: ranging from Ramel (2004) where the total N = 22; up to 
Kuyken (2008) which had a total N = 123. Kuyken (2008) and Williams (2008) were 
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Randomised Controlled Trials (RCTs); Kingston (2007) used a quasi-randomised 
design (consecutive referrals were alternately allocated to the two groups) and 
Ramel (2004) matched the control group on age, gender and baseline BDI score. All 
studies reported good matching on baseline characteristics; and investigated a form 
of MBT for depression. 
 
The results of the meta-analysis are shown graphically in Figure 13. The overall 
effect size was significant. The unstandardised reduction score between intervention 
and control = 4.86; 95% CI LL 1.18, UL 8.54; z = 2.59; p < 0.01). Hedges’ g was also 
calculated (g = 0.4; 95% CI LL 0.07, UL 0.73; z = 2.36; p = 0.02). This assumes 
baseline scores are comparable between intervention and control groups and uses 
only the post-treatment values between these groups. The analysis was weighted 
according to derSimonian and Laird’s method (DerSimonian & Laird, 1986), which 
was the default method within the statistical software for random effects models (Bax, 
et al., April 2008). 
 
The unstandardised reduction score presented for the individual studies in Figure 13 
are calculated as the difference in change scores between intervention and control 
groups. These change scores are presented in Table 12. For example, in 
Kingston (2007) the change score was 18.00 points on the BDI in the intervention 
group and 7.09 points within the waiting list control group. The unstandardised 
reduction score was therefore 10.91 points. There was considerable variation 
between these unstandardised reduction scores as they ranged from 1.55 to 10.91. 
The Q-Test for heterogeneity between these studies was not significant (QT = 4.33; 
df = 3; p = 0.231) and this was anticipated by the amount of variation between the 
individual effect sizes. This suggested they might not be drawn from different 
populations, however the power of this test was very low as the number of studies 
was small (k = 4). 
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Table 12. Summary data for studies included in BDI effect size compared to control (k = 4) 
Intervention Control 
Lead author 
(year) Design Type N 
Pre-treatment 
BDI score 
Mean (SD) 
Post-
treatment BDI 
score 
Mean (SD) 
Change 
score 
Type* N 
Pre-treatment 
BDI score 
Mean (SD) 
Post-
treatment BDI 
score 
Mean (SD) 
Change 
score 
Kingston (2007) Pre-post two groups MBCT 8 30.33 (7.66) 12.33 (9.72) 18.00 TAU 11 29.18 (9.35) 22.09 (8.99) 7.09 
Kuyken (2008) RCT MBCT 61 18.51 (10.91) 13.12 (10.85) 5.39 m-ADM 62 20.15 (12.86) 17.47 (12.67) 2.68 
Ramel (2004) Pre-post two groups MBSR 11 12.54 (10.61) 9.45 (6.73) 3.09 WL 11 13.09 (7.26) 11.55 (7.83) 1.54 
Williams (2008) RCT MBCT 28 15.6 (13.84) 8.7 (11.95) 6.9 WL 27 12.80 (9.55) 12.26 (11.19) 0.54 
* Control group type included: maintenance Anti-Depressant Medication (m-ADM); Waiting List (WL); or Treatment As Usual (TAU) 
 
 
Mindfulness therapy Control group Weight Histogram Unstandardised reduction
Study ID n Mpre  – Mpost  (SD) n Mpre  – Mpost  (SD) (%) of weights score w ith 95% CI
Kingston (2007) 8 18 (7.66) 11 7.09 (9.35) 18.00% |||| 10.91 (3.25  to  18.57)
Kuyken (2008) 61 5.39 (10.91) 62 2.68 (12.86) 39.00% |||||||||||| 2.71 (-1.5  to  6.92)
Ramel (2004) 11 3.09 (10.61) 11 1.54 (7.26) 18.00% |||| 1.55 (-6.05  to  9.15)
Williams (2008) 28 6.9 (13.84) 27 0.54 (9.55) 24.00% |||||||| 6.36 (0.09  to  12.63)
META-ANALYSIS: 100% ||||||||||||||||||||||||||||| 4.86 (1.18 to 8.54)
-10 -5 0 5 10 15 20
MD
 
Figure 13. Forest plot of unstandardised effect size of change in BDI score, studies with control groups (k = 4) 
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3.3.3.1 Moderator analysis 
This analysis investigated whether study design was a moderating variable in the 
observed effect. It compared controlled (both randomised and matched; k = 4) with 
uncontrolled studies (k = 7). The analysis used an inverse variance-weighted ANOVA 
model. 
 
Table 13 shows the effect sizes for the two groups in the moderator analysis 
separately. The effect sizes used were for the intervention group only in the 
controlled studies to more directly compare with the controlled studies (which 
accounts for the differences to the effect sizes reported in Section 3.3.3). The test for 
between-group differences was not significant (QT = 0.32; df = 1; p = 0.573) which 
does not suggest controlled designs was an important moderator effect within the 
intervention groups. As the 95% CIs overlap this adds further to there being no 
significant difference. 
 
Table 13. Effect sizes of a control group, major component studies with BDI outcome 
Comparison k N Combined Effect Size 
95% CI 
(LL, UL) 
Combined 
z score 
Combined 
p value 
Uncontrolled studies 7 219 9.24 6.42, 12.06 6.43 0.000 
Controlled studies 4 108 7.86 3.99, 11.74 3.98 0.000 
 
3.3.4 Reduction in Beck Anxiety Inventory (BAI) scores 
As well as the effect on depression, I was interested in the effect mindfulness 
interventions may have on anxiety. The BAI is one of the most commonly used 
measures of anxiety and a total of k = 7 of the studies used it as an outcome; this 
made it the most appropriate anxiety outcome for meta-analysis. These studies are 
individually detailed in Table 14 and summarised in Table 15. There was a total of 
N = 168 participants: this figure comprises of the total number of analysed 
participants across the studies, within the mindfulness treatment groups only (if 
applicable). 
 
Three of these studies treated depression as the index condition; two treated anxiety; 
one study treated Attention Deficit and Hyperactivity Disorder (ADHD) and one eating 
disorder. All of the studies except Kristeller (1999) had an initial treatment period of 
eight sessions over eight weeks. Kristeller (1999) had a six-week course of treatment. 
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Table 14. Studies included in meta-analysis of the average reduction in BAI scores, pre- and post-treatment 
Lead author (year) Design Intervention Diagnostic 
group 
Treatment 
duration, 
weeks 
Treatment 
group N 
analysed 
Pre-
treatment 
Mean (SD) 
Post- 
treatment 
Mean (SD) 
Eisendrath (2008)  Pre-post single group MBCT Depression 8 51 13.38 (8.76) 9.78 (6.38) 
Evans (2008)  Pre-post single group MBCT Anxiety 8 11 19.00( 13.70) 8.91 (7.80) 
Finucane (2006) Pre-post single group MBCT Depression 8 13 32.00( 12.50) 20.54 (17.08) 
Kabat-Zinn (1992) RCT MBSR Anxiety 8 22 20.53 (13.24) 9.0 (9.14) 
Kristeller (1999)  Pre-post single group MB-EAT Eating disorder 6 18 16.3 (13.45) 10.9 (13.02) 
Williams (2008) Pre-post single group MBCT Depression 8 28 11.37 (9.64) 9.40 (9.22) 
Zylowska (2008) Pre-post single group MAP ADHD 8 25 7.2 (3.1) 4.1 (2.6) 
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Table 15. Descriptive statistics for the BAI means of the included studies (k = 7, 
N = 168) 
Statistic Pre-treatment Post-treatment 
Unweighted mean 17.11 10.38 
Unweighted SD 7.99 4.97 
Median 16.30 9.40 
Skewness (SE) 0.98 (0.79) 1.51 (0.79) 
 
Pre-treatment mean BAI scores ranged from 7.2 (SD = 3.1) in Zylowska (2008)’s 
study of ADHD, which was on the borderline with the range for mild anxiety (range for 
mild anxiety 8-15). The maximum pre-treatment BAI score was 32.0 (SD = 12.5) in 
Finucane (2006). This was in the range for severe anxiety (for which the range was 
26-63). Similarly, the lowest post-treatment score (4.1; SD = 2.6) – was within the 
‘minimal’ range for anxiety - was reported in Zylowska (2008); a study which 
investigated ADHD. The highest post-treatment score was similarly reported in 
Finucane (2006) and was 20.54 (SD = 17.08); which was within the ‘moderate’ 
severity range for anxiety. These are shown graphically in Figure 14. 
 
Treatment duration was comparable across studies: seven of the studies were of 
eight sessions over eight weeks. The exception was Kristeller (1999) which was six 
sessions over six weeks. All of the studies were of group interventions. 
 
Since all studies in Table 14 used the BAI, the pre- to post-treatment raw mean 
difference was used as an effect size representing the average reduction over the 
course of therapy (that is the mean reduction score = Meanpre – Meanpost). These are 
presented for the individual studies in Table 16. Again, only one of these studies - 
Eisendrath (2008) - reported the value of the pre-post correlation. The weights in 
Table 16 were therefore calculated assuming a modest pre-post correlation of the 
BAI scores of r = 0.6 which allows considerable differences in the individual 
responses to therapy. All studies reported a significant (p < 0.05) reduction in the BAI 
scores. 
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Figure 14. Box plot, pre- and post-treatment mean BAI scores (k = 8, N = 139) 
 
 
 
Table 16. Effect sizes for the individual studies, BAI pre- to post-treatment 
Lead author (year) Mean  
Reduction Score 
SE Weight 
Eisendrath (2008)  3.60 0.96 1.09 
Evans (2008)  10.09 3.01 0.11 
Finucane (2006) 11.46 3.71 0.07 
Kabat-Zinn (1992) 11.53 2.17 0.21 
Kristeller (1999)  5.40 2.79 0.13 
Williams (2008) 1.97 1.59 0.39 
Zylowska (2008) 3.10 0.51 3.82 
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Descriptive statistics for the overall effect sizes are presented in Table 17 and shown 
graphically in the form of a box plot in Figure 15. 
 
Table 17. Descriptive statistics for mean reduction score of BAI, pre-post treatment 
Statistic Value 
Unweighted mean 6.74 
Unweighted SD 4.17 
Median 5.40 
Skewness (SE) 0.21 (0.79) 
 
 
 
Figure 15. Box plot of unstandardised reduction score of BAI, pre- to post-treatment 
 
Table 18 details the mean reduction in score as a percentage of pre-treatment score 
for each of the studies included in this analysis. These reductions are based on the 
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means for all participants within the studies on the BAI. The reductions range from 
17% to 56% of the pre-treatment scores. Spearman’s correlation coefficient of the 
pre-treatment BDI score and the reduction from pre- to post-treatment was highly 
significant (ρ = 0.929; p = 0.003). 
 
Table 18. Percentage reduction pre-post treatment in BAI scores, major component 
therapies 
Lead author 
(year) 
Pre-treatment 
Mean 
Percentage reduction 
Eisendrath (2008) 13.38 27% 
Evans (2008) 19.00 53% 
Finucane (2006) 32.00 36% 
Kabat-Zinn (1992) 20.53 56% 
Kristeller (1999) 16.3 33% 
Williams (2008) 11.37 17% 
Zylowska (2008) 7.2 43% 
 
As these studies provided data for BDI and BAI outcomes, it was interesting to 
consider the relationship between the improvements on these two scales. Using 
Spearman’s Rank correlation coefficient the relationship for all of the studies together 
was not significant (k = 7; ρ = -0.036; p = 0.939). Interestingly however if the two 
studies that investigated anxiety conditions are taken out, Evans (2008) and Kabat-
Zinn (1992), the correlation was perfect (k = 5; ρ = 1; p = 0.000). 
 
Figure 16 shows a funnel plot with a symmetrical distribution around the mean effect 
size. This suggests publication bias was unlikely in these studies. Furthermore the fail 
safe N calculation found that 13 ‘hidden’ studies reporting a zero reduction in the BAI 
scores were required to bring down the observed effect sizes of an average reduction 
of 5.64 points to a very small effect size of just 2 points on the BAI. It was possible 
such a number of unpublished studies exist and so publication bias may nullify my 
result however I think this was unlikely as this number represents more studies than 
those entered into the analysis. 
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Figure 16. Funnel plot of unstandardised effect size for BAI, pre- to post-treatment 
 
The meta-analysis for this group of studies was reported in Table 19. Using the 
random effects model, it calculated an unstandardised reduction in BAI score of 5.64 
(95% CI = LL 3.29, UL 8.00; p < 0.00). 
 
Table 19. Results of meta-analysis of BAI, pre- and post-treatment 
Comparison k N Combined Effect Size 
95% CI 
(LL, UL) 
Combined 
z score 
Combined 
p value 
Major component, 
BAI reduction 7 168 5.64 3.29, 8.00 4.70 0.000 
 
The test for heterogeneity between the studies (Q-Test) was significant (QT = 24.85, 
df = 6, p = 0.000), which suggests that the studies were not drawn from the same 
population and so the combined effect size should be interpreted with caution. The 
heterogeneity in the effect size distribution between the studies indicated that a 
moderator analysis would be justified to identify factors explaining this variation. 
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However due to the total number of studies being small (k = 8) it was considered 
inappropriate to conduct moderator analyses. 
 
3.4 Mindfulness as a minor component of therapy 
This part of the meta-analysis aimed to answer the following question: 
“Are therapies which include mindfulness as a minor component of the 
therapy effective in treating anxiety?” 
 
A total of eight studies were eligible for this part of the analysis and these studies are 
summarised in Table 20. More detail on the studies was provided in the 
Appendix (6.4). Most of these studies did not have a control group design (k = 5); the 
others were RCTs (k = 3). The analysis included only the mindfulness treatment 
group arm, where applicable, because of the small number of controlled studies. The 
eight studies reported on a total of N = 139 analysed participants from the 
intervention groups. All of these studies investigated anxiety conditions and the 
specific diagnoses included Generalised Anxiety Disorder (GAD; k = 3); Social 
Anxiety Disorder (SAD; k = 2); mixed anxiety and depression (k = 1); ‘anxiety 
disorders’ (not further specified) (k = 1); and trichotillomania (k = 1). 
 
Across the studies, the total number of hours of treatment ranged from six hours to 
20 hours; occurring over between four and sixteen weeks. A number of different 
treatments were investigated within the studies. Therapies included in this analysis 
were Acceptance and Commitment Therapy (ACT; k = 4); Acceptance-Based 
Behaviour Therapy (ABBT; k = 2); a Buddhist Counselling Programme (BCP; k = 1); 
and Metacognitive Therapy (MCT; k = 1). 
 
The mean age of participants was provided in seven of the studies and these ranged 
from 31.0 years to 42.4 years. All of the studies provided the gender of the 
participants and the proportion of females ranged from 50% to 89.3%. Seven of the 
studies detailed the training of the therapist(s) providing the treatment in the study. 
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Table 20. Studies included in meta-analysis of therapies with mindfulness as a minor component, pre- and post-treatment (k = 8, N = 139) 
Lead author (year) Design Intervention* Diagnosis N 
Treatment 
duration, 
weeks 
Treatment 
duration, 
hours 
Mean age Percentage female 
Therapist 
training 
detailed 
Dalrymple (2007) Pre-post single group ACT SAD 16 12 12 31.0 52.8 Yes 
Forman (2007) RCT 
ACT 
Anxiety and 
depression 
37 15 15 27.8 80.2 
Yes 
Ossman (2006) Pre-post single group ACT SAD 12 10 20 42.4 50.0 Yes 
Roemer (2007) Pre-post single group ABBT GAD 16 16 18 36.4 56.3 Yes 
Roemer (2008) RCT ABBT GAD 15 16 18 33.6 71.0 Yes 
Rungreangkulkij (2008) Pre-post single group BCP Anxiety disorder 21 4 6 42.1 81.0 Yes 
Wells (2006) Audit MCT GAD 10 3-12† --  60.0  
Woods (2006) RCT ACT‡ Trichotillomania 12 12 -- 35.0 89.3 Yes 
* Interventions were: Acceptance and Commitment Therapy (ACT); Acceptance-Based Behaviour Therapy (ABBT); Buddhist Counselling Programme (BCP); and 
Metacognitive Therapy (MCT). 
† Wells (2006) was an audit of treatment: as such there was no pre-specified treatment duration. 
‡ The treatment also included habit reversal training (for trichotillomania). 
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The outcomes used in this analysis are detailed in Table 21, along with pre- and post-
treatment means and weighted standardised reduction score. The weighting used for 
this analysis was the inverse of the variance. As a number of different scales are 
used in this analysis it was appropriate to use a standardised reduction score for the 
effect size. All of these outcomes were the self-rated current anxiety state (subjective 
measures). 
 
Table 21. Outcome measures used in the analysis of mindfulness-based therapies for 
treating anxiety (k = 8, N = 139) 
Lead author 
(year) 
Anxiety 
outcome 
measure* 
Pre-treatment 
Mean (SD) 
Post-
treatment 
Mean (SD) 
Weighted 
standardise
d reduction 
score 
Weight 
Dalrymple (2007) SPAI-sp 130.81 (31.26) 97.48 (32.05) 1.05 11.81 
Forman (2007) BAI 13.42 (10.2) 10.32 (9.57) 0.31 43.57 
Ossman (2006) SPAI-sp 138.25 (24.4) 118 (24.4) 0.83 10.49 
Roemer (2007) DASS-Anxiety 16 (9.44) 4.88 (6.06) 1.40 8.98 
Roemer (2008) DASS-Anxiety 12.53 (1.95) 5.52 (1.35) 4.18 1.57 
Rungreangkulkij 
(2008) 
STAI-St 61.29 (8.56) 48.57 (11.2) 1.28 13.01 
Wells (2006) BAI 21 (9.67) 3.4 (4.12) 2.37 2.77 
Woods (2006) PAI-Anxiety 63.8 (12.4) 58.3 (9.7) 0.49 13.01 
* Outcomes included: Social Phobia and Anxiety Inventory – social phobia subscale (SPAI-sp); Beck 
Anxiety Inventory (BAI); Depression and Anxiety Stress Scales—Anxiety subscale (DASS-Anxiety); 
State–Trait Anxiety Inventory – State measure (STAI-St); and the Personality Assessment Inventory-
Anxiety subscale (PAI-Anxiety). 
 
The summary statistics for the standardised reduction scores for the studies used in 
this analysis are presented in Table 22. The studies covered a wide range of effect 
sizes (0.31 – 4.18) and their distribution was shown graphically in Figure 17. There 
was one outlier in the distribution, Roemer (2008). As well as reporting a 
considerable reduction in raw score, the study also reported very small SDs around 
these values, which also contributed to the very large effect size. This outlier 
significantly skews the distribution, as the skewness statistic was over twice its 
standard error. 
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Table 22. Descriptive statistics for the standardised mean differences in anxiety 
scores, pre-post treatment (k = 8) 
Statistic Value 
Unweighted mean 1.49 
Unweighted SD 1.26 
Median 1.16 
Skewness (SE) 1.65 (0.75) 
 
 
 
Figure 17. Box plot of standardised mean differences across studies in analysis of 
mindfulness-based therapies for treating anxiety 
 
The meta-analysis for this group of studies was reported in Table 23. Using a random 
effects model, it calculated a statistically significant standardised reduction score of 
1.24 (95% CI = LL 0.70, UL 1.77; p < 0.000). 
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Table 23. Results of meta-analysis of standardised mean differences of anxiety 
scores, pre- and post-treatment 
Comparison k N Effect size 
95% CI 
(LL, UL) 
Combined 
z score 
Combined 
p value 
Minor component 
studies, anxiety 
outcomes 
8 139 1.24 0.81, 2.10 4.56 0.000 
 
The test for heterogeneity between the studies (Q-Test) was highly significant 
(QT = 43.29, df = 7, p < 0.000), which suggests that the studies were not drawn from 
the same population and so the combined effect size should be interpreted with 
caution. 
 
Table 24 provides the mean reduction in score as a percentage of pre-treatment 
mean score. These reductions are based on the means for all participants within the 
studies. The reductions cover a very wide range: from 9% to 84% of the pre-
treatment scores. Spearman’s correlation coefficient of the pre-treatment score and 
the standardised effect size was not significant (ρ = -0.464; p = 0.294). 
 
Table 24. Percentage reduction pre-post treatment in BAI scores, minor component 
therapies 
Lead author (year) Anxiety outcome 
measure 
Pre-treatment 
Mean 
Percentage 
reduction 
Dalrymple (2007) SPAI-sp 130.81 25% 
Forman (2007) BAI 13.42 23% 
Ossman (2006) SPAI-sp 138.25 15% 
Roemer (2007) DASS-Anxiety 16.0 70% 
Roemer (2008) DASS-Anxiety 12.53 56% 
Rungreangkulkij (2008) STAI-St 61.29 21% 
Wells (2006) BAI 21.0 84% 
Woods (2006) PAI-Anxiety 63.8 9% 
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Figure 18. Funnel plot of standardised mean difference for anxiety scores, pre- to 
post-treatment 
 
The funnel plot (Figure 18) of the distribution of the standardised effect sizes has an 
outlier to the top-left of the graph; other than this the distribution around the mean 
effect size appears symmetrical. As the outlier was to the left rather than the right of 
the graph (reporting a lower than expected effect size) it suggests publication bias 
was unlikely for this analysis. However the number of studies in the plot was small 
(k = 8). The fail safe N calculation found that 25 ‘hidden’ studies reporting a zero 
reduction in the BAI scores were required to bring down the observed effect size of 
1.24 to a very small effect size of 0.2. As it was unlikely that such a large number of 
unpublished studies exist this value would suggest publication bias was unlikely to 
nullify my result. 
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3.5 Mindfulness as a major vs. minor component of therapy 
This part of the meta-analysis aimed to answer the following question: 
 “In the treatment of anxiety, are there any differences in the effectiveness of 
studies for which mindfulness comprises a major component compared with 
those for which mindfulness comprises a minor component?” 
 
Anxiety was chosen as the condition under investigation because it provided the 
largest number of therapies within the two groups. This analysis was conducted to 
determine whether the ‘amount’ of mindfulness was associated with therapeutic gain 
in anxiety scores. This was conceived as essentially a dose-response analysis; 
studies were categorised as having mindfulness as a minor component of the therapy 
or as a major component (see Table 25). To minimise the amount of data previously 
presented, only variables pertinent to these analyses are detailed. Yook (2008) and 
Koszycki (2007) were not included in previous analyses however more detail on 
these two studies can be found in the Appendix (6.4). 
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Table 25. Major and minor component therapies included in meta-analysis of the mean reduction in anxiety scores, pre- and post-
treatment 
Lead author (year) Design Diagnosis N Intervention Mindfulness 
component Anxiety outcome measure* 
Dalrymple (2007) Pre-post single group SAD 16 ACT Minor SPAI-sp 
Forman (2007) RCT Anxiety and 
depression 
37 ACT 
Minor BAI 
Ossman (2006) Pre-post single group SAD 12 ACT Minor SPAI-sp 
Roemer (2007) Pre-post single group GAD 16 ABBT Minor DASS-Anxiety 
Roemer (2008) RCT GAD 15 ABBT Minor DASS-Anxiety 
Rungreangkulkij (2008) Pre-post single group Anxiety disorder 21 BCP Minor STAI-St 
Wells (2006) Audit GAD 10 MCT Minor BAI 
Woods (2006) RCT Trichotillomania 12 ACT Minor PAI-Anxiety 
       
Yook (2008) Pre-post single group GAD 19 MBCT Major HRS-A 
Kabat-Zinn (1992) Pre-post single group GAD 22 MBSR Major BAI 
Koszycki (2007) RCT SAD 26 MBSR Major LSAS-fear 
Evans (2008) Pre-post single group GAD 11 MBCT Major BAI 
* Anxiety outcomes not previously mentioned include: Hamilton Rating Scale for Anxiety (HRS-A); and the Liebowitz Social Anxiety Scale-Fear (LSAS-fear). 
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In this analysis there were a total of 12 studies. Eight of these had mindfulness as a 
minor component and four had mindfulness as a major component. For those with 
mindfulness as a minor component, the total N = 139; for mindfulness as a major 
component, N = 78. 
 
Table 26 shows the descriptive statistics for these two groups of therapies. The 
distributions are shown graphically in Figure 19. 
 
Table 26. Descriptive statistics for standardised mean differences in anxiety scores, 
overall for major and minor component mindfulness therapies 
Statistic Minor component (k = 8) 
Major component 
(k = 4) 
Unweighted mean 1.49 1.62 
Unweighted SD 1.26 1.14 
Median 1.16 1.17 
Skewness (SE) 1.65 (0.75) 1.72 (1.01) 
 
For studies with mindfulness as a major component, from Figure 19 we can 
determine there was a positive skew to the distribution. Although the skew was quite 
large, it would still be considered approximately normal. 
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Figure 19. Box plot of standardised mean differences for studies with mindfulness as 
a minor and a major component of the therapy separately 
 
The results of the meta-analysis are displayed in Table 27. These analyses used 
random effects models. Both analyses found a statistically significant effect of the 
therapies. Interestingly however, the major-minor comparison did not reveal a 
noticeable difference between these two groups. The test for between-group 
differences was not significant (QT = 0.27; df = 1; p = 0.605) and furthermore there 
was considerable overlap between their respective 95% CI suggesting that there was 
no significant difference between these therapies when grouped in this way. 
 
Table 27. Meta-analysis of effect on anxiety of studies with mindfulness as a minor 
component, major component 
Comparison k N Effect size 95% CI (LL, UL) 
Combined z 
score 
Combined p 
value 
Minor component, anxiety 8 139 1.24 0.71, 1.77 4.56 0.000 
Major component, anxiety 4 78 1.48 0.74, 2.22 3.91 0.000 
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3.6 Chapter summary 
I found evidence of effectiveness for the mindfulness-based therapies included in my 
analyses. These therapies appeared to be effective in reducing affective 
symptomatology across a number of Axis 1 conditions. It appeared unlikely that 
publication bias affected these results and some of the moderator analyses 
conducted returned significant findings. However all of these results need to be 
considered objectively and discussed further. 
Thesis Page 102 
4. Discussion 
4.1 Chapter outline 
In this final chapter I consider my findings and discuss them in detail, with reference 
to the theoretical model of mindfulness within a therapeutic setting. I discuss the 
strengths and limitations of my research. Finally, I consider what the implications of 
my findings are for research and for practice. 
 
4.2 The effectiveness of Mindfulness-Based Therapies 
Overall, I found evidence for the effectiveness of Mindfulness-Based Therapies 
(MBT) in reducing levels of depression or anxiety mainly in patients diagnosed with 
depressive or anxiety disorders. Other diagnostic groups - that was eating disorders 
and Attention Deficit and Hyperactivity Disorder – did also benefit from MBT. I will 
discuss these findings based on the separate analyses I conducted. 
 
The effect sizes discussed here have been estimated using random or mixed effects 
models. It is important to reiterate the difference in interpreting effect size parameters 
for the fixed as opposed to the random effects model (see also 2.6.3). A basic fixed 
effects model rests on the theoretical assumption that there is just one true effect – or 
‘fixed’ effect - for a given intervention, however weak or strong this effect size may 
be. The observed variation in the effect sizes between studies is explained by a fixed 
effects model as being the result of the sampling error associated with each study. If 
the variation of the effect sizes is considerable, however it is likely that there are 
hidden systematic differences between the studies that enhance or hinder the 
effectiveness of the intervention. The difference may be for example the intensity or 
quality of the treatment. In the case of hidden systematic difference, a moderator 
analysis is required to uncover those important conditions which alter the degree of 
effectiveness for that treatment. 
 
Within the context of psychotherapy research, the idea of a single true effect 
parameter, which is constant across a range of intervention studies, appears 
unrealistic. This is because both the therapeutic settings as well as the psychological 
conditions of the individual clients tend to vary considerably, even within the same 
diagnostic group. This variation can be regarded as ‘natural’ or ‘unique’ and is 
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generated by the interaction of the individuals involved – the clients (participants), 
therapists and researchers - in a specific context each with specific intentions and 
needs. A random effects model takes into account this ‘natural randomness’ between 
the studies. Rather than assuming just one true effect for an intervention, a random 
effects model replaces the notion of a single fixed effect with the idea of a distribution 
of effect parameters. Consequently a random effects model differentiates between 
two types of random error: sampling error within each study; and natural randomness 
between the studies. 
 
The estimated average effect size of a random effects model is therefore a 
characteristic of the distribution of the effect sizes in all studies assumed to exist 
which employ a specific intervention. Since the random effects model regards the 
studies included in the meta-analysis as a sample of these studies, it enables the 
researcher to generalise the findings to the population of studies (Hedges & Vevea, 
1998; Lipsey & Wilson, 2000). By contrast, a fixed effects model can never generalise 
the validity of its findings beyond those studies that were actually included in the 
analysis. 
 
4.2.1 Mindfulness as a major component of therapy 
The first aim of the meta-analysis was to establish whether therapies for which 
mindfulness formed a major component of the intervention were effective in treating 
various mental health problems. Therapies defined as having mindfulness as a major 
component were Mindfulness-Based Cognitive Therapy (MBCT); Mindfulness-Based 
Stress Reduction (MBSR); Mindful Awareness Practices (MAP); and Mindfulness-
Based Eating Awareness Training (MB-EAT).  Table 28 provides a summary of the 
main findings from this meta-analysis. This section included a total of 11 studies. 
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Table 28. Main results of the major component meta-analyses 
Comparison k N Combined 
effect size 
95% CI p value 
Depression (BDI) 11 327 8.73 6.61, 10.86 0.000 
Moderator analyses      
Gender (% female) 11 327 0.202* 0.071, 0.333 0.026 
      
Type of therapy (MBCT) 7 251 9.82 7.06, 12.57 0.000 
(other) 4 76 6.85 3.18, 10.52 0.000 
      
Therapist training (detailed) 6 135 6.91 4.24, 9.59 0.000 
(not detailed) 5 192 10.47 7.77, 13.17 0.000 
      
Diagnostic group (depression) 7 251 9.63 6.81, 12.45 0.000 
(other) 4 76 7.24 3.50, 10.97 0.000 
 
     
Controlled studies 4 219 4.86 1.18, 8.54 0.01 
Uncontrolled studies 7 219 9.24 6.42, 12.06 0.000 
Controlled studies 4 108 7.86 3.99, 11.74 0.000 
      
Anxiety (BAI) 7 168 5.64 3.29, 8.00 0.000 
* This was the unstandardised parameter; all other effect sizes are unstandardised reduction 
scores 
 
4.2.1.1 Pre-post treatment reduction in depression scores 
This analysis found that for depression as an outcome there was a significant 
average pre-post reduction of 8.73 points on the BDI (Table 28) corresponding to a 
standardised effect size of 0.84 using the average standard deviation (SD) of the 11 
pre-treatment SD (see Table 5) as the standardising variable. This suggests that 
therapies with mindfulness as a major component of the therapy are effective in 
treating current active depression, as measured by the Beck Depression Inventory 
(BDI). 
 
It was important however to also consider whether this effect size was clinically 
significant. On the Beck Depression Inventory (BDI), clinical significance is normally 
indicated by a change in score which crosses the cut-off point for ‘caseness’ – that is 
minimal to mild depression. For the BDI-II, 0-13 represents minimal depression; 
14-19 mild depression; 20–28 moderate depression; and 29–63 severe depression. 
Therefore a score that moves from a value of 14 or over to a value of 13 or less 
would be considered a clinically significant reduction. 
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The problem was that the studies varied considerably in their pre-treatment mean 
score and furthermore, as it was the mean score it cannot convey clinically significant 
benefit for the individual participants. For example, Kingston (2007) reported the 
largest drop and the treatment group’s mean BDI score was in the ‘severe’ range. 
Ramel (2004) reported the smallest drop, however the starting mean BDI score in the 
treatment group was within the range that indicated ‘minimal’ depression (note that 
the diagnosis for Ramel (2004) was for a lifetime mood disorder and participants 
were participants did not need to be actively depressed). In analysing these data I 
found a link between the pre-treatment score and the reduction in depression score 
(ρ = 0.845; p = 0.001): the greater the severity the greater the reduction. This positive 
correlation was to be expected as it may be related to the famous ‘regression toward 
the mean’ phenomenon (Casella & Berger, 2001); where extreme scores at the end 
of the distribution of a variable have a greater potential for a change back towards the 
centre of the distribution. 
 
4.2.1.2 Moderators of effectiveness 
The result of the Q-test for homogeneity of the effects sizes suggested that the 
studies differed to the extent that moderator analyses were indicated. Several 
promising moderators were considered for a univariate mixed effects model analysis 
(Viechtbauer, 2005, 2007). However it is important to remember that the overall 
number of studies in the group was small (k = 11) and so the estimates of the random 
variance component may not be fully reliable. 
 
Gender was coded in each of the studies as the percentage of females and 10 
studies were included in this analysis. The relationship between effect size and 
gender was statistically significant and a marked degree of correlation was found 
(r = 0.698). The greater the proportion of females in the studies the greater the 
reduction in BDI score and this accounted for almost half of the variation in these 
scores. It is important though to not misinterpret this finding as simple gender effects 
as this would amount to an ecological fallacy (Robinson, 1950). Few studies reported 
information on gender differences so this correlation involves two aggregated 
variables (that is the effect size and the number of females). Whilst it tentatively 
suggests differential effectiveness of MBT for gender, this would have to be 
confirmed in a new meta-analysis involving effect sizes for both genders. 
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Another important point to note in this context is that moderator analyses provide 
evidence of an association: it is not possible to draw conclusions about causality. It is 
possible that the variables in the moderator analyses are confounders, which are 
linked to both outcome and a third variable. For example, all of these studies 
investigated the intervention in a group format. It is possible that women may respond 
better to these therapies than men in a group rather than an individual format. 
 
Type of therapy was considered as a moderator by grouping MBCT (k = 7) and the 
other therapies separately. This attempted to determine whether therapy type 
accounted for some variation in the score. This finding was not significant and so it 
was not yet possible to conclude that MBCT was superior in its effectiveness 
compared to other major component therapies. 
 
A further moderator analysis considered whether reporting of therapist training could 
account for a significant proportion of the variance in the BDI score. About half of 
these studies reported therapist training (k = 6). The analysis found a trend towards 
significance (p = 0.0649). Interestingly, this suggested that the effect size was greater 
by 3.5 points on the BDI in those studies which did not report training. However this 
could be explained by the higher mean pre-treatment score - of 3.5 points – across 
the studies not reporting training compared to those reporting training. This could 
again be because more severe participants were treated who had a much larger 
potential for a reduction in their symptoms. 
 
Within this analysis I used quality of reporting as a proxy for the quality of training. I 
reasoned that if consideration was paid to the degree of training then it would be 
reported. However other factors (for example, article length) may also account for the 
lack of reporting. Using reporting as a proxy is not unusual within research. The most 
well-known examples are quality rating scales, which judge the methodological rigour 
of studies by how well they are reported (Jadad, et al., 1996). 
 
The final moderator analysis looked at diagnostic group and compared depression 
(k = 7) with other mental health conditions. I did find a slightly higher effect size for 
the depression studies, although this was not statistically significant. Although not 
significant, I think the finding of a mean difference of 2.4 points on the BDI was 
actually quite interesting. It suggests that a reduction in depression scores was 
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obtained irrespective of the actual index condition. So for example, MTB was equally 
effective in reducing depression score for clients with ADHD as it was for those 
consulting with depression. It was recognised that this analysis was limited because 
the diagnostic grouping was crude; however the limited number of studies precluded 
more specific grouping. 
 
4.2.1.3 Studies with a control group 
Four of the studies included in the analysis of reduction in BDI score were controlled. 
All of these studies were of depression, although there were some differences in the 
form of the control group. I was interested in a meta-analysis of this subgroup 
because controlled studies tend to apply more stringent inclusion and exclusion 
criteria. This was done in order to generate homogenous groups of participants to 
strengthen the internal validity when comparing them on the outcome measures. 
 
In this meta-analysis, which looked at the differences in the average change from 
pre- to post-treatment between the therapy and control group, and a significant 
reduction of 4.86 points in BDI score was found in favour of the therapy group. This 
was smaller than for the controlled and uncontrolled studies combined, which looked 
at the reduction pre- to post-treatment within the therapy groups only. The reason for 
the smaller amount of reduction was because there was also improvement in each 
control group. This was particularly the case in the two control groups that received 
other types of treatment; but far less in the two WL control groups (see Table 12). 
Furthermore, the lower limit of the 95% CI was 1.61 which represents a minimal 
change of questionable clinical significance. 
 
What this finding suggests is that the effect size for a psychological intervention tends 
to be smaller when it is calculated relative to the amount of improvement within a 
control group, rather than as a simple pre-post reduction score within the intervention 
group only. Unfortunately the small number of studies within this subgroup precluded 
further investigation. A useful further analysis, for example, could have looked at 
comparing waiting list controls with ‘active’ controls to establish the degree of 
spontaneous remission or expectancy effects. It is however questionable whether 
there is much real difference. A waiting list control for psychological therapy may well 
be receiving other forms of care concurrently and so may improve somewhat anyway. 
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4.2.1.4 Reduction in anxiety scores 
The Beck Anxiety Inventory (BAI) is one of the most widely used measures of anxiety 
symptomatology and was used as an outcome in seven of the studies. I found that 
using this as an outcome, MBT did reduce anxiety symptoms (Table 28). The effect 
size was small - 5.64 points on the BAI - but significant in the random effects model. 
This corresponds to a standardised effect size of 0.53 using the average SD of the 
seven pre-treatment SD (see Table 15) as the standardising variable. 
 
These studies included three depression and four other diagnostic groups (see Table 
12). As I investigated BAI reduction in these studies it was perhaps unsurprising that 
the reduction was less than that seen with a measure of depression. Perhaps this 
should particularly be the case as for example MBCT was specifically designed to 
target depression and the cognitive component of the therapy therefore addressed 
depression. However it was interesting that there was a significant reduction in these 
scores and this supplements the findings in the subsequent analysis discussed 
below. 
 
Furthermore, there appeared to be a strong general improvement in anxiety and 
depression scores when considering those studies which did not have anxiety as the 
index condition (k = 5; ρ = 1; p = 0.000). When all studies were considered together, 
there did not appear to be any relationship between improvement in anxiety and 
improvement in depression scores (k = 7; ρ = -0.036; p = 0.939). 
 
4.2.2 Mindfulness as a minor component of therapy 
The aim of the meta-analysis was to establish the effectiveness of therapies 
considered to have mindfulness as a minor component. These ‘minor component’ 
studies included Acceptance and Commitment Therapy (ACT); Acceptance-Based 
Behaviour Therapy (ABBT); a Buddhist Counselling Programme (BCP); and 
Metacognitive Therapy (MCT). A total of eight studies were included in this analysis. 
 
In this analysis most of the studies were single-group designs (k = 5) however there 
were three Randomised Controlled Trials (RCT). I therefore conducted a meta-
analysis of the amount of reduction in anxiety levels from pre- to post-treatment in the 
intervention groups only. A total of 139 participants were included. Only four of the 
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studies used the BAI, so a standardised mean reduction score (Morris & DeShon, 
2002) was used for the effect size in order to compare studies with different anxiety 
outcome measures. All of the outcomes were subjective measures of anxiety 
symptomatology. 
 
I found a significant effect for these studies in the random effects model with a 
standardised mean difference of 1.24 (95% CI = 0.81, 2.10). This suggests a 
considerable reduction - well above 1 standard deviation - indicating a very strong 
effect. However the significant test for heterogeneity was significant suggests this 
should be interpreted with caution. Further moderator analyses were indicated by this 
finding however as the number of studies within the original pool was small (k = 8), 
they were not conducted. 
 
4.2.3 Mindfulness as a major vs. minor component of therapy 
The final analysis used the studies included in the analysis of treatment for anxiety 
disorders. It compared the studies with mindfulness as a minor component (k = 8) 
with those defined as having mindfulness as a major component (k = 4). Again it 
used the anxiety outcomes and so the standardised mean difference for the effect 
size. For both groups there was a statistically significant effect and interestingly, it 
found very similar effect sizes for these two groups of studies. For those with 
mindfulness as a minor component the effect size was 1.24 (95% CI 0.71, 1.77); and 
as a major component 1.48 (95% CI 0.74, 2.22). Although the effect size for the 
major component group was slightly larger, unsurprisingly the confidence interval was 
wider as there were fewer studies in this group and there was considerable overlap 
between these two confidence intervals. However for both groups the lower value of 
the confidence interval indicated a medium to large effect size. 
 
I think what was interesting about this finding was that the amount of mindfulness did 
not seem to make a difference to the size of the effect – there did not appear to be a 
‘dose-response’ relationship. These therapies were equally effective irrespective of 
the amount of mindfulness involved. However it was difficult to definitively state 
exactly how much mindfulness was included in the ‘minor’ component group; or 
indeed how much was actually practised by the participants within the ‘major’ 
component studies. Although it was easier to know how much was taught within the 
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major component group as these studies employed a group format with clearly 
defined treatment manuals. 
 
With the minor component studies, the amount of mindfulness teaching involved was 
often stated for the purpose of the research. With ACT in practice, it is often a clinical 
decision. It will depend on the individual’s presentation and more or less emphasis 
will be placed on it accordingly – or the intervention will be tailored to the individual 
(Steven C. Hayes, Strosahl, & Wilson, 1999). Again however, it was difficult to state 
how much it was actually practised as ‘homework’. There is a considerable 
requirement placed on home practice with MBCT; typically up to 45 minutes a day, 
five days a week during the duration of the course (Segal, et al., 2002). Ideally, 
measures of mindfulness would help establish the extent to which improvement in 
clinical symptomatology is coupled with improved mindfulness skills. 
 
In this analysis I pooled anxiety conditions. Of the 12 studies, six included 
participants with a diagnosis of Generalised Anxiety Disorder, two of which may have 
had an accompanying diagnosis of panic disorder. Of the remaining five studies, 
three included participants with a diagnosis of Social Anxiety Disorder; one anxiety 
and depression; one included any anxiety disorder; and one trichotillomania. I think if 
the number of studies were greater it would have been useful to conduct a moderator 
analysis to determine whether some anxiety conditions were more responsive to 
these approaches. However the numbers prevented this particularly as these 
diagnoses were more similar than in the moderator analysis for the major component 
studies (reported in Section 4.2.1.2 above). 
 
4.2.4 Summary of main findings 
My findings suggest that MBT are an effective treatment for reducing current, active 
anxiety and depression. In the introduction I discussed the basic model of 
mindfulness, which suggests mindfulness works by changing the relationship with 
inner experience. If thoughts are not ‘bought’ – if there is less attachment to our 
thoughts and less belief in them as true - then the model suggests they will have less 
impact on affect. Negative thoughts are an important component in the development 
and maintenance of depression and anxiety. If the relationship between thought and 
emotion is changed – and becoming aware of automatic negative thought processes 
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would be the first step - a corollary would be that the experience of symptomatology 
will be less painful. There is an important paradox at work within mindfulness 
practise. By changing or letting go of the desire to reduce symptomatology and by 
developing a more accepting attitude towards one’s suffering, it paradoxically 
reduces it.   By striving less and letting go of the desire to get rid of the symptoms, 
they are reduced (Steven C. Hayes, et al., 1999; Segal, et al., 2002). 
 
4.3 Limitations of my findings 
4.3.1 Studies not included in these analyses 
I think the most serious limitation of my meta-analysis was that I was not able to code 
and include all of the relevant studies I identified. Almost half of the studies (n = 19) 
entered into the meta-analysis study pool were not included in any of the analyses. 
These exclusions were made because the scope of this project meant it was not 
possible to conduct a comprehensive analysis of all of the studies. Therefore 
decisions were made on which data to include. The pool included studies 
investigating a number of different conditions, using a number of different outcomes 
at different follow-up points. The decisions were pragmatic based on what meaningful 
analyses could reasonably be conducted, with the largest number of studies. 
 
Not all forms of therapies considered to include a mindfulness component were 
included. In some cases this was because retrieved studies did not fulfil the criteria – 
and were therefore excluded in the eligibility screen - however this was not always 
the case. The most notable was Dialectical Behaviour Therapy (DBT), which actually 
accounted for the greatest number of effectiveness studies retrieved and assessed 
for eligibility. The majority of these investigated Borderline Personality Disorder rather 
than Axis 1 disorders, and so were not eligible. However there has been some recent 
interest in applying DBT to a number of other conditions. These include depression 
(Goldstein, Axelson, Birmaher, & Brent, 2007; Harley, Sprich, Safren, Jacobo, & 
Fava, 2008; Lynch, et al., 2007); ADHD and Oppositional Defiant Disorder 
(Hesslinger, et al., 2002; Nelson-Gray, et al., 2006; Philipsen, et al., 2007)]; and 
binge eating disorder (Telch, Agras, & Linehan, 2001). Unfortunately these studies 
did not fit into any of the analyses conducted. 
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4.3.2 Study coding 
It was necessary to group together in my analysis disparate conditions; for example 
anxiety, depression, eating disorder and ADHD. This introduces heterogeneity and 
was a decision informed by the questions asked of these data. This type of grouping 
has precedent in the meta-analytic literature and is acceptable if it is done 
appropriately with a clear rationale. For example, a landmark meta-analysis published 
in a leading medical journal (Linde, et al., 1997) pooled all studies of homeopathy – 
irrespective of condition – into the main analysis. The paper investigated whether 
there was any evidence for homeopathy over and above placebo. It was therefore 
appropriate as it was done with reference to the hypothesis. 
 
It was acknowledged that this may have resulted in a loss of some meaning, however 
I think it was a more pragmatic approach to these data; especially considering the 
limited number of studies. The DSM-IV (American Psychiatric Association, 2000) 
categories are a form of short-hand for clinicians and in summarising the evidence 
provide a useful structure. In the real-world of practise however it is unlikely that 
DSM-IV criteria will be applied to every client and furthermore, there exists 
controversy over the use of diagnoses. It is more likely that the question asked will be 
something like, “will this therapy reduce anxiety or depression in my client?” and this 
question may be asked irrespective of the index condition. 
 
4.3.3 Possible sources of bias 
One possible source of bias I may have introduced into my research was selection 
bias. This form of bias is where included studies were unrepresentative of the current 
practice of mindfulness therapies. I think this was unlikely. My search strategy was 
comprehensive and I included articles in the English or German languages. The 
databases I searched – psycINFO® and Medline® - were the most comprehensive 
databases available within the fields of psychology and medicine respectively. 
Furthermore I excluded a large proportion of studies at the screening stage, which 
suggests the search strategies were comprehensive. 
 
It was difficult to comment precisely on what may have been missed but I think it 
unlikely there were a considerable number of studies excluded which would affect the 
results. Although I did not include grey literature such as dissertations in my analysis I 
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think it was unlikely that these would represent a radically different approach to the 
use of these therapies or the findings of these studies. However publication bias was 
a possibility – studies which may add to the literature even though they find a 
negative result may not be considered as they are not as interesting. The analyses of 
publication bias I conducted failed to show any indication of a systematic exclusion of 
studies. 
 
I did not include studies which described the intervention as meditation. There were 
also examples in the literature investigating ‘mindful exercise’ (Chow & Tsang, 2007; 
Tsang, Chan, & Cheung, 2008); which could include yoga (Schure, Christopher, & 
Christopher, 2008). Again, this omission reflected the question asked. I was 
interested in modern, psychology-led applications of mindfulness which are typically 
informed by existing psychological theory and practice. 
 
4.4 The strengths of my analysis 
One of the strengths of this study was that it used meta-analytic methods to 
determine the effectiveness of therapies, a well-recognised method of summarising 
evidence which directly informs therapeutic guidelines. 
 
By using anxiety and depression outcomes – and where possible, the same 
outcomes at the same time points – my results were clinically relevant and I think this 
was an important strength of this research. To be meaningful, meta-analysis requires 
an aggregation of data from a number of studies and as these studies were not 
identical, it inevitably required working with what was available. I think this was 
particularly relevant in determining which outcomes to focus on and which to 
combine. Most of the studies presented several outcome measures. Using them all 
would either have prevented a succinct overview of these data, as I would have had 
to report many comparisons; or it would have required aggregation of a number of 
disparate measures. I think it was inappropriate to reduce all outcome measures from 
one study into a single effect size; or even two effect sizes, with one for mental health 
outcomes and one for physical health outcomes. I think this loses too much detail and 
does not answer clinically relevant questions asked of these data. For example, a 
clinical psychologist is more likely to ask, “Will this therapy improve my client’s 
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mood?” rather than, “Will this therapy improve my client’s mental health?” 
Furthermore it may give a misleading impression of these therapies. As an example 
the therapies may have been very effective with depression outcomes but not with 
ADHD outcomes; by pooling these together it would have given a false impression of 
the effectiveness of both. 
 
A further strength of this study was its independence from any one particular 
therapeutic modality. Studies of mindfulness-based therapies are most likely to be 
conducted by practitioners of the therapies. For example, Williams and Teasdale 
(MBCT), Hayes (ACT), Linehan (DBT) and Wells (MCT) are all originators and 
leading researchers for their respective forms of therapy. This may lead to 
confirmation bias in the interpretation of the results to suit pre-conceived ideas about 
the therapy. 
 
4.5 What this adds to the literature 
4.5.1 Implications for research 
I found evidence for the effectiveness of MTB however due to the small number of 
current studies there is a need for further research. The small number of studies 
influenced coding and categorisation and it would be useful for more research to 
allow a meta-analysis of for example, specific types of anxiety disorder. 
 
There is considerable interest in operationalising of mindfulness as a concept to allow 
direct measurement. A number of recently developed measures attempt to assess 
factors unique to the method of treatment by quantifying what is purported to be the 
target of the practice of mindfulness; although the difficulties inherent in these 
attempts is recognised (Grossman, 2008). However these have proliferated, 
reflecting variation in definition (see 1.3.1). At the time of writing I was aware of over 
10 measures of either mindfulness or constructs related to the concept of 
mindfulness. The earliest developed scales are beginning to find their way into the 
effectiveness literature, such as the Mindful Attention Awareness Scale (K. W. Brown 
& Ryan, 2003); and the Freiburg Mindfulness Inventory (FMI; Walach, Buchheld, 
Buttenmuller, Kleinknecht, & Schmidt, 2006). 
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When considering the effectiveness of therapy it is important to consider whether 
treatments have a lasting effect. Currently the lack of adequate follow-up limits the 
usefulness of these data on the effectiveness of MBT. For example, one study (Miller, 
et al., 1995) which was considered for inclusion presented the three-year follow-up 
data from an earlier trial (Kabat-Zinn, et al., 1992). This study would have been a very 
useful addition to the analysis however there were no other studies with a similar 
length of follow-up to appropriately combine with these data. One scale developed for 
assessing the quality of psychological therapies (Yates, Morley, Eccleston, & 
Williams, 2005) considers treatment follow-up of less than six months as 
‘inadequate’. I think studies with follow-up less than this period do still provide useful 
data however are limited. I think there are problems inherent in longer trials and so 
pragmatically it is not always possible to undertake them. One of the most relevant 
factors is that attrition usually increases with longer follow-up so there are 
considerable resource implications for running longer studies. Furthermore longer 
follow-up increases the chance of the use of other therapies or life changes which 
may affect outcome scores and be difficult to control for between groups. 
 
A limitation of my findings stems from the number of uncontrolled studies in the 
literature. I aimed to include both controlled and uncontrolled studies to ensure a 
more comprehensive consideration of the effectiveness of MBT. However the number 
of controlled studies was disappointingly small. Controlled studies can provide a more 
robust estimate of effectiveness. 
 
Furthermore, the types of control used in the studies are also relevant. Waiting list 
(WL) or treatment as usual (TAU) controls are the most common encountered within 
these MBT studies. Within a TAU comparator there may for example be considerable 
variation in what participants receive and in a WL control attempts to get better may 
be wither consciously or unconsciously deferred by participants. Furthermore MTB is 
a novel therapeutic approach which is generating considerable interest in the 
scientific literature (Figure 3). This will undoubtedly be reflected in the media 
(University of Iowa Health Care). It is possible that this may create expectancy effects 
influence either the therapist or the participants’ engagement and inflate outcomes 
when there is no control group. 
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My research highlighted a number of issues relating to the quality of reporting. Useful 
moderator analyses were prevented by lack of description within the studies. For 
example, more description on the training of therapists, particularly with regard to 
their own practise, would be useful. More detail provided and discussion in the 
analysis would also be useful. The meta-analysis reported here highlights the 
difficulty in determining a mechanism of therapeutic action. The current literature fails 
to consistently report on variables which may mediate the effect and thus help 
determine a mechanism of therapeutic action. This lack of reporting has been noted 
elsewhere (Singh, Lancioni, Wahler, Winton, & Singh, 2008). I think a consensus 
statement providing guidelines on the reporting of mindfulness research would be a 
useful addition to the literature. 
 
A useful controlled addition which is a good example of a more sophisticated use of 
controls will be Abbot et al. (2007, 2009; in preparation). This study had three arms 
comparing mindfulness training, CBT, and waiting list control groups and furthermore, 
a long follow-up period. This may answer questions regarding the effectiveness as 
compared to other forms of therapy – as well as the specific effects of mindfulness – 
and of its lasting benefit. The study investigated Generalised Anxiety Disorder and 
randomised approximately 100 participants and followed the participants up over 
19 months. Unfortunately these data could not be included in my research. Although 
the study was summarised in an earlier book chapter (Abbott, 2007) at present not 
enough information has been published to allow meta-analysis. I contacted Maree 
Abbott who provided some useful additional data (Abbott, 2009), which unfortunately 
was still not enough information to allow inclusion in this meta-analysis. Abbott’s 
maternity leave prevented her providing a more detailed summary and the 
forthcoming publication is eagerly anticipated (Abbott, et al., in preparation). 
 
Dismantling studies could also potentially provide useful information about the 
relative benefit of the mindfulness component of therapy. All of the therapies detailed 
here have other components and while my crude categorisation of minor component 
vs. major component did not show any difference in effect between the two, it only 
included a small number of studies in each group. The more recent forms of MBT 
have a considerable component of ‘other’ psychological therapy. It is not clear 
whether mindfulness and these other components have a synergistic effect and the 
ideal balance between these components, if indeed there is an ideal. It is unclear 
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whether a more individualised treatment programme is the best option. It is 
notoriously difficult however to tease apart specific and non-specific effects of 
therapies (Fisher, McCarney, Hasford, & Vickers, 2006). For example, presenting a 
formulation brings an expectation of expertise. This expectation may then produce or 
influence an effect. 
 
A recently reported study (Carmody & Baer, 2009) suggests research is becoming 
more sophisticated and answering questions about for example how best to 
implement these therapies. This study looked at the relationship between effect size 
and the number of class contact hours and found no significant difference. This has 
implications not just for resources but I think raises important questions about home 
practice, which have been investigated before. Home-practice has been monitored 
(Gross, et al., 2004) and when the aim is to undertake 45 minutes a day, five days a 
week it is a considerable commitment (Allen, et al., 2006) which is not always 
followed. Other studies have asked about the skills practised in DBT (Lindenboim, et 
al., 2007) and adherence to practice is an important variable for longer-term follow-
up. An early study which looked at the continuing meditation practise for individuals 
referred for relaxation training found over half had stopped their practise (Delmonte, 
1988). However this study was small (n = 38), focused only on one type of condition 
(relaxation training; it is possible that once the desired result was achieved 
participants gave up the practice); and looked at meditation, which requires 
considerable commitment in terms of time. Modern MBT practices tend to try and 
integrate practice more into the ‘modern lifestyle’, for example the ‘three-minute 
breathing space’ and ‘mindful walking’ (Segal, et al., 2002). 
 
I think there is a considerable need for additional qualitative research to determine to 
provide useful insight into clients’ experiences of these therapies. There are some 
good examples already in the literature (Carroll, Lange, Liehr, Raines, & Marcus, 
2008; Fonteyn & Bauer-Wu, 2005; Higginson & Mansell, 2008; Hodgetts, Wright, & 
Gough, 2007; A. Smith, Graham, & Senthinathan, 2007). A good example which 
shows how this type of research can add value is Fonteyn (2005). This study used 
qualitative methodology to amend the mindfulness techniques and then subsequently 
tested them using quantitative methodology. I think these studies provide useful 
evidence into the acceptability and popularity of MBT; however they could also inform 
the development of these therapies. 
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I think another important consideration for future research is the use of outcomes with 
client-generated variables. This would be more in keeping with the idea of getting in 
touch with values, which is explicit in the ACT model and arguably implicit in the other 
forms of MBT. 
 
There has also been a very recent and interesting look at how similar our Western 
concept of mindfulness is to the Eastern concept (Christopher, Christopher, & 
Charoensuk, 2009) – and found that there may be important differences in the 
relative conceptualisations. Revisiting the idea of the origins of mindfulness, I think 
this may highlight that there is still much to research from the ancient practices but 
also much to learn about how these can be augmented with modern Western 
psychological technologies. 
 
4.5.2 Implications for practice 
In considering the implications for practice, I will recap on what was known about 
these therapies from other published reviews. I outlined some of the issues with 
these reviews in my introduction (see 1.8.2); here I will summarise the findings as 
they were reported. 
 
Öst (2008) found in his meta-analysis of that ACT and DBT were effective therapies 
for psychiatric disorders, with effect sizes of 0.66 and 0.58 respectively. Coelho, 
Canter & Ernst (2007) did not attempt to combine these data however reported there 
was evidence that MBCT providing additional benefit to standard care for the 
treatment of recurrent depression (three or more episodes). Toneatto & Nguyen 
(2007) also did not attempt to meta-analyse these data and reported there was no 
evidence supporting MBSR (and MBCT) for the treatment of active anxiety and mood 
disorders. A descriptive review of ACT and DBT by Hayes et al. (2004) reported 
evidence of effect over a wider range of conditions. Grossman et al. (2004) reviewed 
MBSR across all studies of psychological as well as physical health conditions. The 
meta-analysis found evidence of effectiveness and reported an effect size of 0.54 for 
mental health outcomes. Finally Baer (2003) reported for MBCT and MBSR an 
overall weighted effect size of 0.59; and in the subgroup analyses an effect size of 
0.86 for depression measures and 0.70 for anxiety measures. The findings of these 
reviews, along with the findings of my review, were summarised in Table 29 below. 
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Where applicable the most relevant results in those meta-analyses conducted are 
presented and for clarity, studies identified by lead author and year. 
 
Table 29. Summary findings of reviews of Mindfulness-Based Therapies 
Study Included 
therapies 
Conditions Meta-
analysis 
Effect 
size* 
Evidence of 
effectiveness? 
McCarney (2009) MAP 
MBCT 
MBSR 
MB-EAT 
 
ABBT 
ACT 
BCP 
MCT 
 
 
 
(Axis 1) 
psychological 
disorders 
 
 
0.84† 
0.53 
 
 
 
1.24 
 
      
Öst (2008) ACT 
DBT 
Psychiatric disorders 
 
0.66‡ 
0.58  
Coelho (2007) MBCT Recurrent depression  --  
Toneatto (2007) MBCT 
MBSR 
Anxiety and mood 
disorders  --  
Hayes (2004) ACT 
DBT 
All clinical and non-
clinical populations  --  
Grossman 
(2004) MBSR 
All health problems 
 0.54§  
Baer (2003) MBCT 
MBSR 
All health problems 
 
0.86† 
0.70  
* All reported effect sizes are standardised mean differences 
† Effect size presented separately for measures of depression (top line) and measures of anxiety 
(bottom line)  
‡ Effect size presented separately for ACT studies (top value) and DBT studies (bottom value) 
§ All ‘mental health’ outcomes 
 
My research suggests that based on current evidence, mindfulness-based therapies 
have a role in reducing current distress from anxiety and depression in psychological 
conditions. 
 
In treating depression, the early application of mindfulness-based therapies was 
MBCT in the prevention of relapse (Segal, et al., 2002). Early clinical trials of MBCT 
(Ma & Teasdale, 2004; Teasdale, et al., 2000) reported a significant reduction in 
relapse rates for individuals with three or more episodes of depression. Limited 
support for this was reported in Coelho et al.’s (2007) review however Toneatto and 
Nguyen (2007) found no evidence of effectiveness in treating mood disorders in 
general from the controlled research. 
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My findings therefore represent an important addition to the effectiveness literature 
for depression. Recent research has shown an interest in MBCT for treating active 
depression and my findings support the application of MBT with mindfulness as a 
major component in this condition. Furthermore, there was some evidence supporting 
this from controlled studies. 
 
Some of the earliest research into MBT – specifically MBSR - was in its application 
for treating anxiety. Only the Toneatto and Nguyen (2007) specifically looked at 
anxiety disorders and this did not find any evidence of effectiveness within the 
controlled literature. I did not look separately at the controlled literature however I did 
include these study designs. I found evidence of effectiveness for both minor and 
major component MBT in reducing anxiety symptomatology. This also represented an 
important addition to the literature. 
 
I have concentrated on outcomes measuring symptomatology as this was the focus 
within these studies. Using studies of symptomatology for outcome in MBT 
represents an interesting issue. Theoretically, the intended aim of increased 
mindfulness is not to target symptomatology directly rather it is to change the 
relationship with that symptomatology. We may still have negative thoughts, however 
they have less influence. This suggests it will not necessarily reduce symptomatology 
scores however paradoxically an increased mindfulness is likely to reduce the 
symptomatology. Within the theory there is the idea of ‘primary’ (or ‘clean’) pain and 
‘secondary’ (or ‘dirty’) pain (Segal, et al., 2002). There is the initial event which we 
cannot change (for example, we feel sad because we are ignored by someone – 
which is primary pain). However it is our response to this difficulty that mindfulness 
targets (for example, the wish to avoid feeling sad – the secondary pain). Therefore 
reducing this distress is likely to reduce overall distress as commonly used measures 
of symptomatology are not sophisticated enough to distinguish between these two 
types of distress. This was supported by my research. 
 
With outcome on the BDI, I did find that the effect size was less – although not 
significantly - when the intervention group was compared to a control group. It was 
unsurprising that the relative reduction in scores was less and this was to be 
expected, particularly with ‘active’ control groups, as one would hope that they will 
Thesis Page 121 
also be producing a clinical effect. It did however find that MTB were more effective 
than the controls used. 
 
The importance of these findings can be seen in relation to currently existing 
guidelines and the amount of detail presented on MBT. For example, a recent 
collaborative publication between the Royal College of Psychiatrists and Royal 
College of General Practitioners (2008) provided guidance on the use of 
psychological therapies in psychiatry and primary care. It gave a very limited mention 
for MBCT as a therapy which has “proven valuable in the prevention of further 
episodes of illness” (p.14: Royal College of Psychiatrists, 2008) – the illness they 
believe it may prevent was unspecified. 
 
Similarly reference to MBT is limited within NICE guidelines. There is no mention of 
MBT in the current anxiety guidelines (McIntosh, et al., 2004), however these are due 
for an update. In their amended depression guidelines focus on the preventative 
aspect of ‘Mindfulness-based CBT’ [sic], stating it, “should be considered for people 
who are currently well but have experienced three or more previous episodes of 
depression, because this may significantly reduce the likelihood of future relapse” 
(p.37: NICE, 2007). Interestingly, it is referred to as mindfulness-based CBT. 
Although MBCT is considered a form of CBT I think this title is potentially misleading. 
It represents a strong association with CBT and may suggest a broader evidence 
base because of this (Adams, 2008). I think it is important to clearly delineate MBT as 
a group of therapies as the approach they take is somewhat different to ‘traditional’ 
CBT. 
 
Some modern CBT techniques do not focus nearly as much on challenging thoughts 
(Butler, Fennell, & Hackman, 2008). A principal difference between traditional CBT 
and MBT appears to be that CBT spends more energy evaluating the validity of 
thoughts by asking if they are true and encouraging individuals to see things from a 
different perspective by challenging thoughts. In contrast, MBT places far more 
emphasis on changing the relationship to thoughts. It promotes meta-cognitive skills, 
where a perspective is gained so that it is possible to stand back from thoughts and 
tolerate them rather than challenge them directly. From this meta-cognitive 
perspective it is easier to see thoughts as mental phenomena, just thoughts, rather 
than as facts. 
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Both these approaches get to a similar position, which is that thoughts are not facts 
and do not have to be accepted as true. The extent to which people in CBT actually 
learn this as a meta-belief is still unclear. For example, someone may learn that their 
thoughts about their anxiety are not accurate. The chest pain is not necessarily an 
indicator of having a heart attack; or people are not as likely to reject me as I thought. 
However they might not get the general rule that thoughts are mental events and not 
facts. Another difference is that CBT holds that we have thinking ‘errors’, whereas 
mindfulness is more concerned with workability or taking ‘skilful action’, and not 
getting tied up into labelling thoughts in this way. Steven Hayes argues that CBT 
starts from an assumption of healthy normality, so depression is dysfunctional and 
different from the norm (Steven C. Hayes, 2008). MBT starts from the assumption 
that suffering is a part of the human condition, which arguably normalises rather than 
pathologises suffering. 
 
Ultimately it was difficult to say whether the mindfulness component was responsible 
for the effectiveness found within this review. However what was clear was that the 
therapy ‘package’ of MBT may provide benefit. When conducting research of this 
nature it is important that it translates into a real benefit in practice. I think the 
conclusion of my research is that some clients can gain from this form of therapy and 
I aim to publish my findings to inform and develop practice. 
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4.6 Conclusion 
Mindfulness-based therapies are an important, current technology within the 
cognitive-behavioural tradition. They have their roots within meditative practice dating 
back thousands of years and their current growth and development within the field of 
clinical psychology are considerable. These therapies are based on changing the 
relationship with difficult inner experience and the theory suggests this may play an 
important role in reducing the impact of affective symptomatology. There is a growing 
evidence base for these therapies however reviews have not comprehensively 
summarised their effectiveness using meta-analytic techniques. My aim was to 
contribute to this evidence base and inform practice, by conducting a meta-analysis 
of these therapies. 
 
I considered these therapies within two main groups: those with mindfulness as a 
major component and those with mindfulness as a minor component. My analysis 
looked at these groups separately and found evidence of effectiveness in reducing 
active depression and anxiety. There were a number of methodological limitations to 
the research. I was not able to include all of the studies I identified and most of the 
included studies were uncontrolled. However these findings represent an important 
addition to the literature which has implications for subsequent research and practice. 
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6.1 Abbreviations and acronyms 
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AG Andrew Grey 
JS Jörg Schulz 
RM Robert McCarney (author) 
SW Susannah Walker 
 
6.1.2 Therapies, outcome measures, statistics and others 
95% CI 95% Confidence Interval 
AAQ-II Acceptance and Action Questionnaire - version 2 
ABBT Acceptance-Based Behaviour Therapy 
ACT Acceptance and Commitment Therapy 
ADHD Attention Deficit and Hyperactivity Disorder 
BCP Buddhist Counselling Programme 
BDI (-II) Beck Depression Inventory (version II) 
BMI Body Mass Index 
CAMS-R Cognitive and Affective Mindfulness Scale-Revised 
CAS Cognitive Attentional Syndrome 
CBASP Cognitive Behavioural Analysis System of Psychotherapy 
CBGT Cognitive Behavioural Group Therapy 
CBT Cognitive Behavioural Therapy 
CM Concentration Meditation 
CT Cognitive Therapy 
DF Degrees of Freedom 
DBT Dialectical Behaviour Therapy 
EBCP Evidence-Based Clinical Practice 
EQ Experiences Questionnaire 
ES Effect Size 
FAP Functional Analytic Psychotherapy 
FFMQ Five Facet Mindfulness Questionnaire 
FMI Freiburg Mindfulness Inventory 
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GAD Generalised Anxiety Disorder 
HDRS Hamilton Depression Rating Scale 
H/O History of 
IBCT Integrative Behavioural Couple Therapy 
k Number of studies (included in meta-analysis) 
KIMS Kentucky Inventory of Mindfulness Skills 
LL Lower Limit (to 95% confidence interval) 
MAAS Mindful Attention Awareness Scale 
m-ADM maintenance Anti-Depressant Medication 
MAP Mindful Awareness Practices 
MBCT Mindfulness-Based Cognitive Therapy 
MB-EAT Mindfulness-Based Eating Awareness Training 
MBPM Mindfulness-Based Pain Management 
MBSR Mindfulness-Based Stress Reduction 
MBRE Mindfulness-Based Relationship Enhancement 
MBRP Mindfulness-Based Relapse Prevention 
MBT Mindfulness-Based Therapies 
MCT Meta-Cognitive Therapy 
MDD Major Depressive Disorder 
MM Mindful Meditation 
MR Mental Retardation 
N Combined number of participants (included in meta-analysis) 
n Number (of citations) 
NHS National Health Service 
NICE National Institute for Health and Clinical Excellence 
NRCT Non-Randomised Controlled Trial 
ODD Oppositional Defiant Disorder 
p Probability value 
PD Panic Disorder 
PDD Pervasive Developmental Disorder 
PMS Philadelphia Mindfulness Scale 
PRISMA Preferred Reporting Items for Systematic reviews and Meta-Analyses  
RCT Randomised Controlled Trial 
RDD Recurrent Depressive Disorder 
QT Q-Test for homogeneity 
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QRCT Quasi-Randomised Controlled Trial 
QUORUM  QUality Of Reporting of Meta-Analyses 
SAD Social Anxiety Disorder 
SMD Standardised Mean Difference 
S-REF Self-Regulatory Executive Function 
SMQ Southampton Mindfulness Questionnaire 
TAU Treatment As Usual 
TMS Toronto Mindfulness Scale 
UL Upper Limit (to 95% confidence interval) 
UT Uncontrolled Trial 
WASI Wechsler Abbreviated Scale of Intelligence 
WL Waiting List 
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6.2 NICE Hierarchy of evidence and recommendation grading 
scheme 
Level  Type of evidence  Grade  Evidence  
I  Evidence obtained from a single 
randomised controlled trial or a 
meta-analysis of randomised 
controlled trials  
A  At least one randomised controlled 
trial as part of a body of literature of 
overall good quality and 
consistency addressing the specific 
recommendation (evidence level I) 
without extrapolation.  
IIa  Evidence obtained from at least 
one well-designed controlled study 
without randomisation  
B  Well-conducted clinical studies but 
no randomised clinical trials on the 
topic of recommendation (evidence 
levels II or III); or extrapolated from 
level I evidence.  
IIb  Evidence obtained from at least 
one other well-designed quasi-
experimental study  
  
III  Evidence obtained from well-
designed non-experimental 
descriptive studies, such as 
comparative studies, correlation 
studies and case studies  
 
 
IV  Evidence obtained from expert 
committee reports or opinions 
and/or clinical experiences of 
respected authorities  
C  Expert committee reports or 
opinions and/or clinical experiences 
of respected authorities (evidence 
level IV). This grading indicates that 
directly applicable clinical studies of 
good quality are absent or not 
readily available.  
 
GPP Recommended good practice 
based on the clinical experience of 
the GDG. 
NICE  Evidence from NICE clinical 
guideline or technology appraisal 
NICE 
 
Adapted from Eccles M, Mason J (2001). How to develop cost-conscious guidelines. Health 
Technology Assessment 5 (16)  
NHS Executive. Clinical Guidelines: Using Clinical Guidelines to Improve Patient Care Within 
the NHS. London: 1996.  
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6.3 Methodology 
6.3.1 Search strategies 
6.3.1.1 psycINFO 
 
 
 
1. mindfulness.mp. or exp Mindfulness/ 
2. MBCT.mp. [mp=title, abstract, heading word, table of contents, key concepts] 
3. MBSR.mp. [mp=title, abstract, heading word, table of contents, key concepts] 
4. DBT.mp. [mp=title, abstract, heading word, table of contents, key concepts] 
5. dialectical behavio*.mp. [mp=title, abstract, heading word, table of contents, key 
concepts] 
6. MB-EAT.mp. [mp=title, abstract, heading word, table of contents, key concepts] 
7. MBRE.mp. [mp=title, abstract, heading word, table of contents, key concepts] 
8. commitment therap*.mp. [mp=title, abstract, heading word, table of contents, key 
concepts] 
9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 
10. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or dummy or mask$)).mp. 
[mp=title, abstract, heading word, table of contents, key concepts] 
11. placebo$.mp. [mp=title, abstract, heading word, table of contents, key concepts] 
12. random$.mp. [mp=title, abstract, heading word, table of contents, key concepts] 
13. crossover.mp. [mp=title, abstract, heading word, table of contents, key concepts] 
14. assign$.mp. [mp=title, abstract, heading word, table of contents, key concepts] 
15. allocat$.mp. [mp=title, abstract, heading word, table of contents, key concepts] 
16. ((clin$ or control$ or compar$ or evaluat$ or prospectiv$) adj25 (trial$ or studi$ or 
study)).mp. [mp=title, abstract, heading word, table of contents, key concepts] 
17. exp Placebo/ 
18. exp Treatment Effectiveness Evaluation/ 
19. exp Mental Health Program Evaluation/ 
20. exp Experimental Design/ 
21. versus.id. 
22. vs.id. 
23. case report.mp. or exp Case Report/ 
24. case series.mp. 
25. interrupted time-series.mp. 
26. case stud$.mp. 
27. (equivalent adj group$).mp. [mp=title, abstract, heading word, table of contents, key 
concepts] 
28. (test adj retest).mp. [mp=title, abstract, heading word, table of contents, key 
concepts] 
29. exp Clinical Trials/ 
30. (clinical adj trial$).mp. [mp=title, abstract, heading word, table of contents, key 
concepts] 
31. 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 
25 or 26 or 27 or 28 or 29 or 30 
32. 9 and 31 
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6.3.1.2 Medline 
 
 
 
1. "randomized-controlled-trial” [Publication Type] 
2. "controlled clinical trial” [Publication Type] 
3. randomized controlled trials as topic [MeSH Terms] 
4. "random allocation” [MeSH Terms] 
5. "double blind method” [MeSH Terms] 
6. "single blind method” [MeSH Terms] 
7. "clinical trial” [Publication Type] 
8. clinical trials as topic [MeSH Terms] 
9. "clin*” [Title/Abstract] AND "trial*” [Title/Abstract] 
10. "sing*" 
11. "doubl*" 
12. "tripl*" 
13. "treb*" AND "blind*" 
14. "mask*" 
15. "dummy*" 
16. "placebos” [MeSH Terms] 
17. "placebo*” [Title/Abstract] 
18. "random*” [Title/Abstract] 
19. "research design” [MeSH Terms] 
20. comparative stud* 
21. evaluation studies as topic [MeSH Terms] 
22. "follow up studies” [MeSH Terms] 
23. "prospective studies” [MeSH Terms] 
24. "control*” [Title/Abstract] 
25. "prospectiv*” [Title/Abstract] 
26. "volunteer*” [Title/Abstract] 
27. "crossover" 
28. "case report” [Title/Abstract] 
29. "case stud*” [Title/Abstract] 
30. "equivalent group*” [Title/Abstract] 
31. "test retest” [Title/Abstract] 
32. "interrupted time series” [Title/Abstract] 
33. (#1) OR (#2) OR (#3) OR (#4) OR (#5) OR (#6) OR (#7) OR (#8) OR (#9) OR (#10) OR 
(#11) OR (#12) OR (#13) OR (#14) OR (#15) OR (#16) OR (#17) OR (#18) OR (#19) OR 
(#20) OR (#21) OR (#22) OR (#23) OR (#24) OR (#25) OR (#26) OR (#27) OR (#28) OR 
(#29) OR (#30) OR (#31) OR (#32) 
34. "mindfulness” [Title/Abstract] 
35. "MBCT” [Title/Abstract] 
36. "MBSR” [Title/Abstract] 
37. "DBT” [Title/Abstract] 
38. "dialectical behavio*” [Title/Abstract] 
39. "MB-EAT” [Title/Abstract] 
40. "MBRE” [Title/Abstract] 
41. "commitment therap*” [Title/Abstract] 
42. (#34) OR (#35) OR (#36) OR (#37) OR (#38) OR (#39) OR (#40) OR (#41) 
43. (#33) AND (#42) 
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6.3.2 Screening form 
Mindfulness-based therapies for psychological conditions  Screening form 
 
Reviewer:  RM / SW 
Citation Retrieve? 
1. Abbott, M., Enhancing outcomes in the treatment of generalised 
anxiety disorder. [References], in Innovations and advances in 
cognitive behaviour therapy, D.A. Einstein, Editor. 2007, Australian 
Academic Press: Bowen Hills, QLD, Australia. p. 157-170. 
 
2. Ackroff, K., F. Lucas, and A. Sclafani, Flavor preference 
conditioning as a function of fat source. Physiology & Behavior, 
2005. 85(4): p. 448-460. 
 
3. Adelman, E.M., Mind-body intelligence: a new perspective 
integrating Eastern and Western healing traditions. Holist Nurs 
Pract, 2006. 20(3): p. 147-51. 
 
4. Alexander, C.N., et al., Transcendental Meditation, mindfulness, 
and longevity: An experimental study with the elderly. Journal of 
Personality and Social Psychology, 1989. 57(6): p. 950-964. 
 
5. Alexander, J.L., et al., Collaborative depression care, screening, 
diagnosis and specificity of depression treatments in the primary 
care setting. Expert Rev Neurother, 2007. 7(11 Suppl): p. S59-80. 
 
6. Alterman, A.I., et al., Pilot trial of effectiveness of mindfulness 
meditation for substance abuse patients. Journal of Substance Use, 
2004. 9(6): p. 259-268. 
 
7. Anderson, N.D., et al., Mindfulness-based stress reduction and 
attentional control. Clinical Psychology & Psychotherapy, 2007. 
14(6): p. 449-463. 
 
8. Arch, J.J. and M.G. Craske, Mechanisms of mindfulness: emotion 
regulation following a focused breathing induction. Behav Res Ther, 
2006. 44(12): p. 1849-58. 
 
9. Asberg, M., et al., [Mindfulness meditation--an old fashion method 
for stress relief]. Lakartidningen, 2006. 103(42): p. 3174-7. 
 
10. Astin, J.A., Stress reduction through mindfulness meditation: Effects 
on psychological symptomatology, sense of control, and spiritual 
experiences. Psychotherapy and Psychosomatics, 1997. 66(2): p. 
97-106. 
 
11. Astin, J.A., et al., The efficacy of mindfulness meditation plus 
Qigong movement therapy in the treatment of fibromyalgia: a 
randomized controlled trial. J Rheumatol, 2003. 30(10): p. 2257-62. 
 
12. …  
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6.3.3 Inclusion form 
Mindfulness-based therapies for psychological conditions  Inclusion form 
 Reviewer:  RM Date: 06/02/09 -  
 
Criteria: 
Criterion 1 (language): English or German (OR contact author to determine 
whether English translation) 
Criterion 2 (design): Any type of experimental design (including non-
randomised) 
Criterion 3 (participants): Any psychological condition typically treated in MH 
services where a formal diagnosis explicitly stated using 
appropriate criteria (and a clinical sample) 
Criterion 4 (sample size): 2+ participants 
Criterion 5 (intervention): Any type of mindfulness practice 
Criterion 6 (observation period): Treatment period 1 week or more with follow-up at end 
of/ post treatment 
Criterion 7 (outcome measure): Any type of validated outcome 
 
INCLUDE: only if trial meets all criteria (place ‘Y’ or ‘N’ in boxes 1-7 
and ‘include’ column) 
 
Lead author (yr) Source 1 2 3 4 5 6 7  INCLUDE? 
Abbott (2007) Innovations and advances in cognitive behaviour therapy          
Alterman (2004) J of Substance Use          
Bach (2002) J of Consulting and Clinical Psychology          
Bohus (2004) Behaviour Research and Therapy          
Bohus (2000) Behaviour Research and Therapy          
Bowen (2006) Psychology of Addictive Behaviors          
Bowen (2007) Addictive Behaviors          
Bradley (2003) J of Traumatic Stress          
Brassington (2006) Australasian Psychiatry          
Carmody (2008) J Psychosom Res          
Chadwick (2005) Behavioural and Cognitive Psychotherapy          
Chen (2008) International J of Eating Disorders          
Clarkin (2007) American J of Psychiatry          
Comtois (2007) Cognitive and Behavioral Practice          
Dalrymple (2007) Behav Modif          
Dams (2007) 
Psychotherapie 
Psychosomatik Medizinische 
Psychologie 
        
 
Eisendrath (2008) Psychotherapy and Psychosomatics          
Evans (2008) J of Anxiety Disorders          
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6.4 Included studies 
Table 30. Details of the studies included in the analyses 
 Methods Participants Intervention  
Study Design3 Duration of 
therapy, 
follow-up 
Diagnosis (criteria 
used) 
Inclusion/ exclusion 
criteria 
Total N 
(treatment, 
control) 
Completers  
(treatment, 
control) 
Age 
Mean 
(SD) 
Sex (M/F) Ethnicity Therapy 
type4 
Number 
and 
duration 
of 
sessions 
Number of 
therapists, 
training 
Control5 
Dalrymple (2007) 1 group 
repeated 
measures 
12 weeks, 
3month 
follow-up 
SAD (DSM-IV) Excluded if diagnosis: 
primary not SAD; 
MR or a PDD; 
psychiatric disorder due 
to medical condition; 
substance dependence 
(<6 months); suicidal; 
medical 
contraindicating 
treatment; 
previous therapy for 
SAD. 
19 enrolled, 
16 
completed 
post-
treatment 
assessment, 
12 follow-up 
31 (10) 52.8%F 63.9% 
Caucasian 
ACT, 
individual 
12 weekly 
1hr 
Doctoral 
students, 3-hr 
protocol 
workshop, 
weekly 
supervision 
N/A 
Eisendrath (2008) Pre-post 
single 
group 
2 months Active treatment 
resistant, major 
depression (DSM-
IV) 
Failure to remit with 2 
previous at least 2 anti 
depressant treatments 
55 enrolled, 
51 
completers 
Range 
22-74yrs 
38F 
(74.5%) 
82% white MBCT 
Group 
8 x 2 hour, 
weekly 
Psychiatrist 
and co-
therapist 
N/A 
Evans (2008) Pre-post 
single 
group 
8 weeks GAD (DSM-IV) 18-80 yrs; medically 
Stable. Exclude if co-
morbid depression; 
substance 
abuse/dependence; 
psychosis. Current or 
homicidal ideation and 
dissociative states. 
12, 11 49 
(Range 
36-72yrs) 
5 M/ 6 F ? MBCT 
Group 
8 weeks of 
2 hours 
1, completed 
internship in 
MBSR 
N/A 
                                               
3
 Coded as either randomised or non-randomised; then study type (e.g. RCT; audit; one-group pre-test post-test) 
4
 Coded as either ACT; DBT; MBCT; MBSR; MBT; MCT; MB-EAT; MBPM; MBRE; MBRP; or detailed if other 
5
 Controls coded as either TAU (treatment as usual); WL (waiting list); AC (attention control); or detailed if active control or medication 
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 Methods Participants Intervention  
Study Design3 Duration of 
therapy, 
follow-up 
Diagnosis (criteria 
used) 
Inclusion/ exclusion 
criteria 
Total N 
(treatment, 
control) 
Completers  
(treatment, 
control) 
Age 
Mean 
(SD) 
Sex (M/F) Ethnicity Therapy 
type4 
Number 
and 
duration 
of 
sessions 
Number of 
therapists, 
training 
Control5 
Finucane (2006) Pre-post 
single 
group 
8 weeks 
Treatment. 
3 months 
until post 
Depression 
Or Depression and 
Anxiety (ICD-10) 
Include if: 
18–65yrs; H/O RDD or 
Depression and 
Anxiety; current 
symptoms>2wks;  
2 previous episodes; 
BDI>14. 
Exclude if: 
organic brain disease. 
Current substance 
misuse; psychosis or 
mania; Personality 
Disorder; suicidal. 
13 
 
43 
(Range 
23-46yrs) 
10 F ? MBCT 
Group 
8 weeks One. 
Meditation 
experience, 
completed 
MBCT 
course, 
further 
training as 
MBCT 
instructor 
N/A 
Forman (2007) RCT Varied: 
Mean 15.27 
sessions 
(CT), 15.60 
(ACT) 
Anxiety and 
Depression 
(DSM-IV) 
Excluded if diagnosis of 
a serious psychiatric 
illness; or presented in 
crisis. 
101 enrolled 
(56 ACT, 45 
CT), 63 
completers 
(37 ACT, 26 
CT) 
27.8 
(7.25) 
80.2% F 64.4% white, 
12.9% black, 
10.9% Asian, 
3.0% Latino 
ACT, 
individual 
At least an 
hour 
weekly 
23 therapy- 
naïve student 
therapists.  
CT 
Kabat-Zinn (1992) 1 group  5 months GAD or PD w/ or 
w/out PD (DSM-III) 
Excluded if other 
primary psychiatric 
diagnosis, psychosis, 
endocrine disorder, 
significant current 
alcohol or substance 
abuse. 
22 38 17 F ? MBSR  
Group 
8 weekly 2 
hour 
session + 
7.5 hour 
“retreat” 
1 per group N/A 
Kenny (2007) Audit 8 weeks Depression 
(DSM-IV) 
Currently depressed 
with 3+ episodes 
depression or chronic 
>1 year at clinical 
interview, Not abusing 
substances. 
50, 
49 
completers 
(46 supplied 
data) 
 43.3 (9.7)  74% F  MBCT Eight 2-h 
classes 
were held 
+ 1 hour 
yoga or 
related 
First author 
(MK), 
psychiatrist, 
cognitive 
therapist 
N/A 
Kingston (2007) Non-RCT 3 months Recurrent MDD 
(DSM-IV) 
>3 previous episodes, 
BDI 13-45. 
Exclude if substance 
dependence, 
psychosis, bipolar 
disorder 
28 enrolled, 
22 
completed 
with 19 
providing 
data (8, 11) 
41.8 
(range 
20-62) 
17 F ? MBCT 
Group 
8 weekly, 
2 hr 
sessions 
2 TAU 
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 Methods Participants Intervention  
Study Design3 Duration of 
therapy, 
follow-up 
Diagnosis (criteria 
used) 
Inclusion/ exclusion 
criteria 
Total N 
(treatment, 
control) 
Completers  
(treatment, 
control) 
Age 
Mean 
(SD) 
Sex (M/F) Ethnicity Therapy 
type4 
Number 
and 
duration 
of 
sessions 
Number of 
therapists, 
training 
Control5 
Koszycki (2007) RCT 8 weeks SAD (DSM-IV) Exclude if HDRS>14; 
other axis 1 other than 
dysthymia, depression, 
panic disorder, 
agoraphobia, GAD, 
specific phobia and 
somatisation disorder; 
lifetime psychosis or 
bipolar; substance 
abuse <12 mnths. 
58 enrolled, 
53 
completed  
(26 
Treatment, 
27 Control) 
38.9 
(15.7) 
25M/ 28F ? MBSR 
Group 
8 2.5 hr 
sessions, 
one all day 
retreat 
(27.5 total) 
1, with  
experience 
CBGT 
Kristeller (1999) 1 group 
pre-post 
6 week Binge Eating 
Disorder 
BMI>27 18 46.5 
(10.5) 
All F 17 white MB-EAT 7 sessions  N/A 
Kuyken (2008) RCT 15 months Recurrent 
Depression 
(DSM-IV) 
3+ episodes; 18+ 
doses ADM<6 mnths;  
current full/ partial 
remission. 
Exclude if substance 
dependence; organic 
brain damage; 
psychosis; Bipolar;  
Anti-Social/ Self-
injurious behaviour;  
concurrent 
psychotherapy 
123 enrolled, 
all analysed 
(61 treat., 
62 ctrl) 
48.95 
(10.55) 
47F 98% white  8 weekly 2 
hr 
sessions; 
4 follow up 
sessions 
over year. 
2, trained by 
Teasdale, 
experienced 
m-ADM 
Ossman (2006) Single-
group 
pre-post 
10 weeks Social anxiety 
(DSM-IV) 
Excluded if active 
substance dependence 
22 enrolled, 
12 
completed 
42.4 11, 11 Not stated ACT, 
group 
10 
sessions, 
2hours 
each 
Two, 
graduate 
students 
(formal 
training, 
weekly 
supervision) 
N/A 
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 Methods Participants Intervention  
Study Design3 Duration of 
therapy, 
follow-up 
Diagnosis (criteria 
used) 
Inclusion/ exclusion 
criteria 
Total N 
(treatment, 
control) 
Completers  
(treatment, 
control) 
Age 
Mean 
(SD) 
Sex (M/F) Ethnicity Therapy 
type4 
Number 
and 
duration 
of 
sessions 
Number of 
therapists, 
training 
Control5 
Ramel (2004) 2 group 
Pre-post 
8 weeks Lifetime diagnostic 
criteria for a mood 
disorder 
Exclude if psychosis, 
substance 
dependence, 
substantial cognitive 
impairment 
Matched 
sample of  
11completer
s and 11  
50.87 
(8.87) T 
35% F 100% white MBSR 
group 
8 weekly 
2 hr 
classes + 
homework 
psychiatric 
nurse 
specialist 
(PEC), who 
has 
participated 
in a 
professional 
training 
program 
under the 
direction of 
Kabat-Zinn, + 
a doctoral 
student 
WL 
 
Data not 
included 
as added 
on 
afterwards
. 
Roemer (2007) Single-
group 
pre-post 
4 months 
treatment, 
3 months FU 
GAD (DSM-IV) 18+yrs. Exclude if 
suicidal intent; bipolar; 
substance 
dependence; 
psychosis. 
16 36.44  
(12.34) 
9 F 15 White, 1 
Latino 
ABBT, 
individual 
16 (4 90-
minute, 12 
60-minute) 
Authors, 
doctoral 
students, one 
postdoctoral 
therapist. 
N/A 
Roemer (2008) RCT 16-32 weeks GAD (DSM-IV) 18+yrs.  Exclude if 
suicidal intent; bipolar; 
substance 
dependence; 
psychosis. 
31 all 
analysed 
(15, 16) 
 
33.59 
(11.74) 
9M/ 22F 27 white, 2 
Latino, 1 
black, 1 
Asian 
ABBT, 
individual 
16 (4 90-
minute, 12 
60-minute) 
Six doctoral 
students 
WL 
Rungreangkulkij 
(2008) 
Single 
group 
pre-post 
1 month 
treatment,  
2 month FU 
‘Anxiety disorder’ Not stated (inpatients) 21 42.1 
(range 
22-56) 
4, 17 Thai BCP, 
individual 
2 60-90 
min 
sessions, 
1 month 
apart (4 
sessions) 
One, 
Buddhist 
belief system 
N/A 
Wells (2006) Open trial 
(audit) 
Varied, 12-
month FU 
GAD (DSM-IV) None stated 10 Range 
25-76yrs 
4M/ 6F Not stated MCT, 
individual 
3-12 
sessions 
Not stated N/A 
Williams (2008) RCT 8 weeks Unipolar or Bipolar 
disorder, in 
remission 
Aged 18-65, ≥1 
episode major 
depression with  
suicide ideation. No 
manic episodes <6 
mnths 
68 (33, 35) 
55 (28, 27) 
Not given 
(no 
difference 
reported) 
Not given 
(no 
difference 
reported) 
Not given MBCT 
group 
8, 2hr 
sessions. 
1 full-day 
Two with 
recognised 
expertise 
WL 
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 Methods Participants Intervention  
Study Design3 Duration of 
therapy, 
follow-up 
Diagnosis (criteria 
used) 
Inclusion/ exclusion 
criteria 
Total N 
(treatment, 
control) 
Completers  
(treatment, 
control) 
Age 
Mean 
(SD) 
Sex (M/F) Ethnicity Therapy 
type4 
Number 
and 
duration 
of 
sessions 
Number of 
therapists, 
training 
Control5 
Woods (2006) RCT 12 weeks, 3 
months 
Trichotillomania 
(DSM-IV) 
>85 on WASI; no 
physical conditions 
preventing 
participation; no mental 
health conditions 
requiring immediate 
attention; no 
psychotherapy for TTM. 
Stable psychotropics 
(>4weeks) 
28 enrolled 
(14/14), 25 
completers 
(12/13) 
35 (10.2) 3, 25 96.4% 
Caucasian, 
3.6% 
African 
American 
ACT and 
habit 
reversal 
training, 
individual 
10 
sessions, 
duration 
not stated 
One, trained 
by originator 
of ACT 
(Hayes) 
WL 
Yook (2008) Pre post 
design 
8 weeks GAD, or PD with or 
without 
agoraphobia 
(DSM-IV) 
Stable symptoms>2 
months, not helped by 
medication. Exclude: 
substance misuse; 
comorbid psychiatric; 
medical problems. 
19 41.1 (6.3) 11/8 ? MBCT 
Group 
8 sessions 
of 2hrs 
each (16 
hours) 
? N/A 
Zylowska (2008) Pre-post 8 weeks ADHD (DSM-IV) 15 yrs+. Exclude if: 
substance dependence 
<6 months; psychosis; 
Bipolar; MR; 
personality disorder; 
conduct disorder; 
suicidal/ self-injurious. 
24 adults & 
8 
adolescents, 
completers: 
18 adults, 7 
adolescents 
48.5 
(10.9) for 
adults,  
15.6 (1.1) 
for 
adoles. 
12 M/ 20 F Not given MAP, 
Group 
8 weekly 
2.5 hrs 
experienced 
mindfulness 
instructor 
N/A 
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6.5 Excluded citations 
Table 31. Ineligible citations 
Citation Reason excluded 
Abbott, M., Enhancing outcomes in the treatment of generalised anxiety disorder. 
[References], in Innovations and advances in cognitive behaviour therapy, D.A. 
Einstein, Editor. 2007, Australian Academic Press: Bowen Hills, QLD, Australia. p. 
157-170. 
Data inappropriate 
Alterman, A.I., et al., Pilot trial of effectiveness of mindfulness meditation for substance 
abuse patients. Journal of Substance Use, 2004. 9(6): p. 259-268. Participants 
Barnhofer, T., et al., Effects of meditation on frontal alpha -asymmetry in previously 
suicidal individuals. Neuroreport: For Rapid Communication of Neuroscience 
Research, 2007. 18(7): p. 709-712. 
Outcomes 
Bohus, M., et al., Effectiveness of inpatient dialectical behavioral therapy for borderline 
personality disorder: A controlled trial. Behaviour Research and Therapy, 2004. 42(5): 
p. 487-499. 
Participants 
Bohus, M., et al., Evaluation of inpatient Dialectical-Behavioral Therapy for Borderline 
Personality Disorder--A prospective study. Behaviour Research and Therapy, 2000. 
38(9): p. 875-887. 
Participants 
Bowen, S., et al., Mindfulness meditation and substance use in an incarcerated 
population. Psychology of Addictive Behaviors, 2006. 20(3): p. 343-347. Participants 
Bowen, S., et al., The role of thought suppression in the relationship between 
mindfulness mediation and alcohol use. Addictive Behaviors, 2007. 32(10): p. 2324-
2328. 
Participants 
Bradley, R.G. and D.R. Follingstad, Group Therapy for Incarcerated Women Who 
Experienced Interpersonal Violence: A Pilot Study. Journal of Traumatic Stress, 2003. 
16(4): p. 337-340. 
Intervention 
Brassington, J. and R. Krawitz, Australasian dialectical behaviour therapy pilot 
outcome study: Effectiveness, utility and feasibility. Australasian Psychiatry, 2006. 
14(3): p. 313-319. 
Participants 
Brotto, L.A., R. Basson, and M. Luria, A mindfulness-based group psychoeducational 
intervention targeting sexual arousal disorder in women. Journal of Sexual Medicine, 
2008. 5(7): p. 1646-1659. 
Participants 
Carmody, J., et al., Mindfulness, spirituality, and health-related symptoms. J 
Psychosom Res, 2008. 64(4): p. 393-403. Participants 
Carson, J.W., et al., Mindfulness-based relationship enhancement. Behavior Therapy, 
2004. 35(3): p. 471-494. Participants 
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